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Abstract 
 
Physiological,  cognitive  and  cortical  arousal  can  interfere  with  sleep  initiation.  Any 
relaxation  technique  may  help  to  reduce  arousal  levels  and  so  facilitate  sleep,  and 
biofeedback  is  a  particular  type  of  self-regulation  procedure.  Both  electromyograph 
(EMG)  biofeedback  and  electroencephalograph  (EEG)  biofeedback  have  been 
investigated as treatments for insomnia.  This review aimed to evaluate the evidence for 
the efficacy of biofeedback as a treatment for insomnia.  Studies were identified by 
searching  electronic  databases,  the  reference  sections  of  relevant  articles  and  the 
contents pages of a key journal. For articles to be selected, it was necessary for the main 
target  problem to  be insomnia and for a group design to  have been employed. The 
outcome measures had to at least include sleep log data. Twelve studies were reviewed 
and discussed in terms of their methodological quality and research findings. There is 
evidence that different procedures targeting physiological, cognitive and cortical arousal 
have  shown  promise  but  the  mechanisms  driving  the  observed  reductions  in  insomnia 
symptoms  are  not  yet  clear.    Many  of  the  studies  reviewed  are  decades  old  and  the 
methodological quality of several of the studies is low according to today‟s standards. The 
results of this review suggest that more research in this area is warranted in order to better 
understand the mechanisms underlying various biofeedback protocols and also to perhaps 
better understand the interaction of arousal and sleep processes.   
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Introduction 
 
Insomnia  is  a  common  problem  in  the  general  population.  Ohayon  (2002)  reported  the 
prevalence of insomnia diagnoses, according to DSM-IV (Diagnostic and Statistical Manual 
of Mental Disorders, 4
th edition; American Psychiatric Association, 1994) criteria, to be 
estimated at 6% with about a third of the general population presenting with at least one 
symptom.    Prevalence  generally  increases  with  age  and  prevalence  rates  are  higher  in 
women than in men and in individuals with other medical or psychiatric diagnoses.  In both 
the  DSM-IV  and  ICSD-2  (International  Classification  of  Sleep  Disorders,  2
nd  edition; 
American Academy of Sleep Medicine, 2005) diagnostic classification systems, insomnia is 
defined by difficulties in initiating or maintaining sleep, or sleep that is non-restorative in 
nature, which results in impairments on daily functioning.  However the systems differ in 
their approach to categorising subtypes. DSM-IV  adopts a much broader approach than 
ICSD-2, which includes a greater number of subtypes.  For example, the DSM-IV diagnosis 
of Primary Insomnia would be applied to all insomnia not induced by substances or due to a 
psychiatric or medical condition, whereas the ICSD-2 system would divide this same group 
into  more  specific  diagnoses  e.g.  Psychophysiological  Insomnia,  Idiopathic  Insomnia, 
Paradoxical Insomnia. Chronic insomnia (defined as >1 month duration in DSM-IV and >6 
months in ICSD-2) can have considerable, negative impact on an individual‟s quality of life 
as well as on health care services (Simon & VonKorff, 1997). 
 
The process of initiating sleep involves reducing physiological arousal levels, as indicated 
by,  for  example,  heart  rate  or  muscle  tone  (Budzynski,  1973;  Ogilvie,  2001).    If 
physiological arousal does not sufficiently reduce, then it can interfere with sleep initiation.  
It has been well documented that individuals with insomnia show higher levels of somatic 14 
 
arousal compared to normal sleepers (Bonnett & Arand, 1996, 1998; Adam et al., 1986; 
Stepanski  et  al.,  1989,  1994;  Haynes  et  al.,  1974;  Haynes  et  al.,  1981;  Monroe,  1967; 
Freedman & Sattler, 1982; Riemann et al., 2010). Cognitive arousal may also interfere with 
both the initiation and the maintenance of sleep e.g. intrusive (often negative) thoughts, and 
excessive worry about sleep difficulties. (Morin, 1993; Perlis et al., 1997; Harvey, 2002). 
Indeed, some studies have reported that cognitive arousal interferes with sleep initiation to a 
greater degree than physiological arousal (Lichstein & Rosenthal, 1980; Robertson et al., 
2007). Harvey (2002) suggests that excessive worry about the consequences of insomnia 
can trigger autonomic arousal and distress.  This then leads to an attentional bias towards 
the sleep difficulty and its perceived consequences, and so to further worry.  The important 
role of selection attentional processes and sleep effort has been discussed in depth by Espie 
et al. (2006). Importantly, however, as Perlis et al. (1997) have suggested, cortical arousal is 
a  useful  construct  for  insomnia  which  serves  to  explain  the  interaction  between  brain 
physiological processes and mental states. Recent work by Cortoos et al. (2011) helpfully 
discusses  not  only  „types‟  of  hyperarousal  in  insomnia  patients  in  comparison  to  good 
sleepers, but also addresses the variability of arousal status which characterises insomnia. 
   
Any relaxation technique may help to reduce arousal levels and so facilitate sleep, and   
biofeedback is a particular type of self-regulation procedure whereby relaxation skills are 
learned through operant conditioning.  In this way, biofeedback training enables individuals 
to develop awareness of, and learn how to control, internal physiological processes that tend 
to occur outside of normal awareness (Budzynski, 1973).  As the term suggests, biofeedback 
involves the measurement of some aspect of biological activity, which is then fed back to 
the  individual,  so  that  they  are  continually  aware  of  the  current  level  of  that  activity.  15 
 
Beta  (≥13  Hz):  Faster,  smaller  brainwaves  –  associated  with  being  alert,  intellectual 
activity and concentration. 
 
Alpha (8-12 Hz): Slower & larger than beta waves – associated with being more relaxed 
and less alert. 
 
Theta (4-8 Hz): Slower and larger than alpha waves - associated with a „daydream-like‟ 
state, deep relaxation and with the transition between awake and sleep states. 
 
Delta (0.5-3.5 Hz): Slowest, largest brainwaves – associated with being asleep. 
 
Hammond (2006) 
 
 
 
 
Feedback is usually by sound, with tones that vary as the level of activity changes, or 
visually using a display.   
 
There are various types of biofeedback, each focusing on learning to control a specific 
process e.g. muscular activity, heart rate, brain activity or skin conductance.  Two types of 
biofeedback have been investigated as treatments for insomnia: electromyograph (EMG) 
biofeedback  and  electroencephalograph  (EEG)  biofeedback,  or  neurofeedback.    EMG 
biofeedback uses surface electrodes to monitor electrical activity of a skeletal muscle.  The 
electrodes are often placed on the frontalis muscle, which is located in the forehead, and a 
noise is produced which varies in tone or frequency to indicate the level of muscular activity.  
The aim is often to decrease the pitch of this noise and so learn to decrease muscle tension 
(Coursey et al., 1980).  The hypothesis behind this intervention in relation to insomnia is 
that by reducing muscle tension, physiological arousal will reduce, which will help with 
sleep initiation.  
 
Neurofeedback uses the EEG to measure and instantly feed back (visually or auditorily) the 
electrical activity of the brain (a proxy for cortical arousal), which occurs across a range of 
frequencies (see below). 16 
 
Brain activity of each frequency band are usually present at all times, however, different 
frequencies are dominant at different levels of awareness (Hammond, 2006). Therefore, 
neurofeedback can be used to inhibit or to reinforce specific EEG frequencies.  Instant 
feedback relating to patterns of brain activity (of which we are not normally aware) is given 
and self-regulation is again acquired through operant conditioning (Cortoos et al., 2006).  
Theta biofeedback, for example, focuses on theta waves, typical of stage 1 sleep and of the 
transition between wakefulness and sleep.  Their presence indicates being in a very relaxed 
state.  The goal of theta feedback is to increase theta activity, and so relaxation, which will 
facilitate  sleep  initiation  (Hauri,  1981).  Another  type  of  neurofeedback  is  sensorimotor 
rhythm (SMR) feedback.  SMR is a low amplitude brainwave rhythm (in the 12-14 Hz 
moderate to fast range), associated with immobility during wakefulness, and localised in the 
sensorimotor cortex (Cortoos et al., 2006). SMR is thought to be associated with stage 2 
sleep and individuals with insomnia seem to produce less SMR during wakefulness than 
good sleepers (Jordan et al.,1976 as cited in Hauri, 1981). So it has been hypothesised that 
increasing  SMR  during  wakefulness  may  improve  sleep  (Hauri,  1981).    There  is  some 
evidence that for individuals with high resting muscle tension, who find it difficult to relax, 
prior  EMG  biofeedback  training  is  necessary  in  order  for  neurofeedback  training  to  be 
effective.  However this did not seem to be necessary in individuals who were already easily 
able to reach a state of relaxed muscle tension (Sittenfield et al., 1972 as cited in Budzynski, 
1973)  
 
The aim of this review is to evaluate the evidence for the efficacy of biofeedback as a 
treatment for insomnia.  Articles investigating the efficacy of any type of biofeedback were 
searched for and considered for inclusion. 
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Method 
 
Search Strategy and Search Terms 
The following electronic databases were searched from the earliest records available until 
July  2011:  Ovid  Medline,  All  EBM  Reviews,  Embase,  CINAHL  Plus,  PsycINFO  and 
Psychology  and  Behavioural  Sciences  Collection.    The  search  terms  used  were: 
„biofeedback‟, „neurofeedback‟, „theta-feedback‟, „insomnia*‟ and „sleep*‟. Truncation was 
used, indicated by *, to find different word endings. Searches were combined using the 
Boolean  commands  „AND‟  and  „OR‟,  and  duplicates  were  removed.    The  search  was 
supplemented  by  searching  reference  sections  of  selected  papers  as  well  as  of  relevant 
review papers which had been identified in the database search (Ebben & Spielman, 2009; 
Lundh,  1998;  Morin,  Culbert  &  Schwartz,  1994;  Morin  et al.,  1999;  Spielman,  Caruso,  & 
Glovinsky 1987).  A search was also carried out of the online contents pages of all issues of 
the journal Applied Psychophysiology and Biofeedback (previously Biofeedback and Self-
Regulation; 1976 – June 2011).   
 
Selection Criteria  
Inclusion and exclusion criteria were employed to select appropriate articles: 
Inclusion Criteria 
  Main target problem of insomnia. 
  Group design 
  Outcome measures to include at least one of the following: sleep-onset latency 
(SOL), wake after sleep onset (WASO), total sleep time (TST) or no. of awakenings. 
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Exclusion Criteria 
  Single case studies, review articles 
  Non English language 
  Participants without sleep difficulties 
  Primary target problem other than insomnia with sleep difficulties being a secondary 
problem. 
 
Methodological Quality Rating 
Studies were evaluated using a modified version of the Clinical Trials Assessment Measure 
(CTAM; Tarrier & Wykes, 2004; Figure 1.1). The CTAM is a measure which was designed 
to  assess  the  methodological  rigour  of  randomised  controlled  trials  of  psychological 
treatments. Its content was influenced by the CONSORT guidelines (Moher et al., 2001), a 
review of trial assessment scales as well as expert opinion.  The CTAM comprises 15 items 
relating to: the participant sample, method of allocation to groups, assessment method and 
measures,  experimental  control,  analysis  of  results  and  the  description  of  treatment, 
including use/adherence to protocol. For the purpose of this review, the „assessment‟ section 
was  slightly  modified  to  make  it  more  applicable  to  the  sleep  research  studies  being 
reviewed, but without altering the weighting of the scoring system.  The weighting system 
was designed to take into account previous evidence regarding the influence of research 
methodology on outcome. For example, a maximum of 10 points are given to items relating 
to  the  participant  sample  and  a  maximum  of  32  points  are  given  to  items  relating  to 
„assessment‟ (see Figure 1.1 for further detail about the allocation of points). Item scores are 
added to reach a maximum of 100.  The CTAM has been shown to demonstrate good inter-
rater reliability (0.96), adequate internal consistency (Cronbach‟s alpha = 0.69) and good 19 
 
criterion validity when compared with other quality assessment scales (Tarrier & Wykes, 
2004). 
 
Fifty percent of the  articles were rated by an independent rater, also a Trainee Clinical 
Psychologist. Initially, 92.5% agreement was achieved.  Differences in ratings were  then 
discussed until 100% agreement was reached.  Using an arbitrary rating system, studies 
were then classified according to their quality rating score as: very low, low, moderate, high 
or very high quality. 
 
0 – 20 = Very low 
21 – 40 = Low 
41 – 60 = Moderate 
61 – 80 = High 
81 – 100 = Very high 
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Figure 1.1: Clinical Trials Assessment Measure (CTAM; Tarrier & Wykes, 2004) – 
Modified 
 
Author(s): 
Title:  
Year:  Journal: 
Reviewer: 
Trial Design Area  Item   Score 
Sample 
(maximum = 10) 
Type of Sample: convenience sample (2); geographic cohort 
(5); highly selective sample (0) 
[Convenience sample:  e.g. clinic attendees, referred patient; Geographic cohort: 
all patients eligible in a particular area; Highly selective: e.g. volunteers] 
 
Sample Size: at least 27 participants in each group or based on 
adequate power calculations (5) 
 
Allocation 
(maximum = 16) 
 
True randomisation or minimisation allocation (10)   
Process of randomisation described (3)   
Process of randomisation carried out independently from the 
trial research team (3) 
 
Assessment (for 
the main 
outcome) 
(maximum = 32) 
 
Assessment carried out by independent assessors (10)   
* Sleep log data  (at least one of sleep-onset latency (SOL), 
wake after sleep onset (WASO), total sleep time (TST) or no. 
of awakenings) or other standardised subjective assessments 
(3)  
and/or... 
Subjective physiological data e.g. polysomnography or EEG 
(3) 
 
Assessments carried out blind to treatment allocation (10)   
Methods of rater blinding adequately described (3)   
Rater blinding verified (3)   
Control groups 
(maximum = 16) 
TAU is a control group (6)  
... and/or a control group that controls for non-specific effects 
or other established or credible treatment (10) 
 
Analysis 
(maximum = 15) 
Analysis appropriate to design and type of outcome measure 
(5) 
 
Analysis includes all participants randomised (intention to 
treat) (6) 
... and adequate investigation and handling of drop-outs from 
assessment if attrition rate exceeds 15% (4) 
 
Active Treatment 
(maximum = 11) 
Treatment adequately described (3)   
Treatment protocol or manual used (3)   
Adherence to the treatment protocol quality assessed (5)   
Total Score =   
 
Where criterion not reached for any question score = 0 
Total maximum score = 100 
* Modified item 21 
 
Results 
 
Search Results 
The electronic database search generated 534 articles.  Fourteen articles were selected on the 
basis of their title or abstract and full text articles were requested.  Thirteen full text articles 
were available for review, 3 of which were subsequently excluded (Appendix 1.2, articles 2-
4).  Ten articles were selected for inclusion and their references then examined, identifying 
two further articles.  Review articles which had been identified in the database search were 
examined for further potentially relevant articles.  The contents pages of all issues of the 
journal  Applied  Psychophysiology  and  Biofeedback  were  also  searched.  However,  no 
further articles were identified. A flowchart illustrating the search process is presented in 
Figure 1.2.  The reasons for the exclusion of articles which had been selected for full text 
review are outlined in Appendix 1.2.  Twelve articles, summarised in Table 1.1, were finally 
included in the review.   
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Ovid database (keyword) search: 
Ovid Medline, All EBM 
Reviews, Embase & Embase 
Classic. 
 
EBSCOhost database (abstract) 
search: CINAHL Plus, 
PsycINFO & Psychology and 
Behavioral Sciences Collection. 
 
357 references identified 
16 references 
selected on basis of 
title and abstract. 
177 references identified 
References in selected 
articles examined for 
further potential 
papers and full text 
articles reviewed if 
possible. 
Review articles which 
were identified in the 
database search were 
examined for any further 
potential papers – no 
further papers identified. 
13 full text articles 
reviewed. 
 3 papers 
excluded. 
(Appendix 1.2, 
articles 2-4) 
10 articles selected on 
basis of inclusion and 
exclusion criteria. 
Not able to obtain 
full text for 1 
reference 
(conference 
publication).  
(Appendix 1.2, paper 1) 
 6 papers excluded. 
(Appendix 1.2, papers 5-10) 
2 further 
papers 
identified 
12 ARTICLES 
IDENTIFIED 
FOR INCLUSION 
Figure 1.2: Flowchart of Literature Search Process 
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Table 1.1: Summary of Selected Articles     
 
Study 
Quality 
Rating 
( max = 
100) 
Participants  Groups 
Treatment 
Length & Follow-
up 
Main Outcome 
Measures  Summary of Main Findings 
Cortoos et 
al. 
(2010a) 
69 
 
High 
17;  sleep-onset or -
maintenance 
insomnia (referred 
patients) 
(12 healthy 
sleepers) 
Mean age: 41.5 in 
neurofeedback 
group; 43.8 in EMG 
group 
Duration: >6months 
 
Neurofeedback 
EMG biofeedback  
Healthy control 
20 sessions over 8 
weeks. 
 
No follow up. 
Home Sleep Log: Total 
Sleep Time (TST), Sleep 
onset latency (SOL), 
Wake after sleep onset 
(WASO), Sleep efficiency 
(SE).  
 
Polysomnography: TST, 
SOL, WASO, SE, 
Percentage of sleep time 
spend in different stages 
of sleep. 
Both treatment groups showed a 
decrease in sleep onset latency. 
Significant increase in total sleep 
time after neurofeedback only. 
Coursey et 
al. 
(1980) 
42 
 
Moderate 
22; chronic sleep-
onset insomnia 
 
Duration:  
at least 2 years, 
average 14 years 
 
Mean age: 38.6 
EMG biofeedback 
Autogenic training 
Electrosleep therapy  
Sessions (35-
40mins), twice 
weekly for 6 
weeks. 
 
Daily home 
practice: EMG 
group 2x daily 
(10mins); 
autogenic 3x daily 
(5-8mins) 
Electrosleep: 5x 
weekly treatment, 
no home practice. 
 
1 month follow up. 
 
 
Home Sleep Log: 
SOL, SE 
 
Sleep-EEG: 
SOL, TST, SE, WASO, % 
REM/Delta sleep.    
EEG sleep records and home 
sleep log showed meaningful 
improvement in 3 biofeedback 
participants, 2 autogenic 
participants and none of the 
electrosleep participants.  The 
biofeedback group showed 
significantly more improved 
patients than the electrosleep 
group. 24 
 
Study 
Quality 
Rating 
( max = 
100) 
Participants  Groups 
Treatment 
Length & Follow-
up 
Main Outcome 
Measures  Summary of Main Findings 
Freedman & 
Papsdorf 
(1976) 
67 
 
High 
18; sleep onset 
insomnia 
(volunteers) 
Duration: at least 6 
months 
Age 17-39 (median 
23) 
EMG biofeedback  
Progressive relaxation 
Placebo „relaxation‟  
6 (30-min) 
sessions over 2 
weeks. 
Daily home 
practice (20-min) 
2 month follow-up 
interview. 
Home Sleep Log: 
SOL 
 
Polysomnography: 
SOL 
Biofeedback and relaxation both 
significantly improved sleep 
onset latency but did not 
significantly differ from each 
other. 
Hauri 
(1978) 
46 
 
Moderate 
37; chronic, severe 
insomnia. Referred 
insomnia patients. 
EMG biofeedback 
EMG/theta feedback 
SMR feedback 
TAU control 
15 - 60 sessions 
 
No follow up at 
time of reporting 
Home Sleep Log: 
TST, SOL, no. 
awakenings 
 
Laboratory: 
SOL, SE, no. 
awakenings, % of sleep 
stages. 
TST and SOL significantly 
improved in EMG biofeedback 
group according to home but not 
lab data. SMR group showed 
improved SOL in home data and 
SE in lab data. 
No significant improvements in 
EMG/theta or TAU control. 
Hauri 
(1981) 
49 
 
Moderate 
46; chronic, serious 
insomnia (referred 
patients & media 
recruited 
volunteers ) 
 
Duration 2-40 years 
(mean 8 years)  
EMG biofeedback  
EMG/theta feedback  
SMR feedback  
No-treatment control 
15 – 62 sessions 
(mean 24.8) 
 
9 months follow up 
Home Sleep Log: 
TST, SOL, no. 
awakenings 
Laboratory: 
SE, SL, no. of 
awakenings, % of 
different sleep stages, no. 
of body movements. 
No significant differences 
between the 3 treatment groups.  
 
Specific types of biofeedback 
may be effective in the treatment 
of specific types of insomnia.  
Hauri et al. 
(1982) 
49 
 
Moderate 
16; chronic 
insomnia 
Theta feedback  
SMR feedback 
About 6 EMG 
sessions as well as 
about 26 theta or 
SMR sessions, 
over 13 weeks on 
average (sessions 
2-3x per week) 
 
9 months follow up 
Home Sleep Log: 
TST, SOL, no. 
awakenings 
Laboratory: 
SE, SL, no. of 
awakenings, % of 
different sleep stages, no. 
of body movements. 
Theta & SMR feedback groups 
showed improved sleep in sleep 
log data.  Sleep lab data 
indicated that tense/anxious 
participants benefited from theta 
feedback only, while those who 
were relaxed at baseline 
benefited only from SMR.  25 
 
Study 
Quality 
Rating 
( max = 
100) 
Participants  Groups 
Treatment 
Length & Follow-
up 
Main Outcome 
Measures  Summary of Main Findings 
Haynes, 
Sides & 
Lockwood 
(1977) 
40 
 
Low 
24;  Moderate 
sleep-onset 
insomnia (uni & 
media recruited 
volunteers) 
Duration: average 
7.1 years 
Mean age: 34.2 
EMG biofeedback 
Relaxation 
instructions 
Control (relaxation 
with no instructions) 
 
6  (30-min) bi-
weekly sessions 
Daily home 
practice at 
bedtime. 
 
3 & 12 months 
follow up 
Home Sleep log: 
SOL, TST, no, of 
awakenings 
Biofeedback and relaxation 
equally effective in treating sleep 
onset insomnia, both 
significantly better than conrol in 
self-report sleep measures. 
Hughes & 
Hughes 
(1978) 
37 
 
Low 
36;  insomnia 
 
Duration: at least 4 
months 
EMG biofeedback 
Pseudo-biofeedback 
Relaxation 
Stimulus control 
training 
Biofeedback and 
pseudo-
biofeedback: 8 
(40-min) sessions, 
4 for relaxation 
and 2 for stimulus 
control training.   
Daily home 
practice (bedtime)  
1 year follow up 
Home Sleep log: 
SOL 
SOL decreased in all four 
groups, no significant differences 
between groups. 
Nicassio, 
Boylan & 
McCabe 
(1982) 
36 
 
Low 
40; Severe insomnia 
(volunteers) 
Duration: average 
11.2 years 
Age 17-64 (mean 
43.5) 
EMG biofeedback 
Pseudo-biofeedback  
Progressive relaxation 
No-treatment control 
10 (30-min) 
sessions over 6 
weeks & daily 
home practice 
(twice daily) 
6 months follow up 
Home Sleep Log: 
SOL, TST, no. 
awakenings, sleep quality 
 
Spouse/roommate reports 
 
Reported SOL decreased in 
progressive relaxation and EMG 
biofeedback. However, neither 
more effective than placebo 
group.  Improvements 
maintained at follow-up 
Sanavio 
(1988) 
42 
 
Moderate 
24; persistent 
psychophysiological 
insomnia (referred 
patients) 
Duration: approx 10 
years (1 – 25 years) 
Clinically referred 
patients 
EMG biofeedback  
(high & low cognitive 
arousal) 
Cognitive treatment 
(high & low cognitive 
arousal) 
6  (35-min) 
sessions over 2 
weeks 
 
3 and 12 months 
follow up 
Home Sleep Log: 
SOL, TST, no. 
awakenings 
 
Spouse/roommate  reports 
 
Both treatments significantly 
improved SOL, TST & sleep 
quality. Neither treatment more 
beneficial than the other or for 
high/low cognitive arousal 
groups. 26 
 
Study 
Quality 
Rating 
( max = 
100) 
Participants  Groups 
Treatment 
Length & Follow-
up 
Main Outcome 
Measures  Summary of Main Findings 
Sanavio et 
al. 
(1990) 
46 
 
Moderate 
40; persistent 
insomnia (both 
sleep onset & 
maintenance) 
 
Duration: 5-25 
years (mean 11.8) 
 
Clinically referred 
participants 
EMG biofeedback 
Cognitive treatment  
Stimulus control & 
relaxation 
Waiting list control 
6 (50-60-min) 
sessions over 2 
weeks  & daily 
home practice 
 
1 & 3 year follow 
ups 
Home Sleep Log: 
SOL, WASO, TST  
 
Spouse/roommate  reports 
 
 
 
Sleep improved in all 3 treatment 
groups. No changes in waiting 
list control. No significant 
differences between treatments. 
Maintained at follow-up. 
VanderPlate 
& Eno 
(1983) 
28 
 
Low 
24; mild insomnia; 
volunteer 
undergraduate 
female students 
 
Duration: 3 months 
– 3 years (mean 1.4 
years) 
 
 
EMG biofeedback 
EMG pseudo-
feedback 
Self-monitoring 
Waiting list 
10 (15-min) 
sessions & daily 
home practice 
 
2 months follow up 
Home Sleep Log: 
SOL, TST 
 
 
Both biofeedback & pseudo-
feedback groups showed reduced 
SOL, no difference between 
groups. Biofeedback but not 
pseudo-feedback showed 
significantly reduced EMG 
levels. 
 
Abbreviations 
Electromyograph (EMG); Electroencephalograph (EEG); Sensorimotor rhythm (SMR); Treatment as usual (TAU) 
 
Total Sleep Time (TST); Sleep onset latency (SOL); Wake after sleep onset (WASO); Sleep efficiency (SE) 
 
Pittsburgh Sleep Quality Index (PSQI; Backhaus et al., 2002); Insomnia Severity Index (ISI; Bastien et al., 2001); Quality of Life Inventory (QOLI; Frisch et al., 
2005) 
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Using the modified CTAM (Figure 1.1), two articles received high quality rating scores, six 
received moderate scores and four received low scores (Table 1.1).  The mean score was 46. 
 
Studies  comparing  the  efficacy  of  EMG  biofeedback  and  relaxation  as  treatments  for 
insomnia will initially be reviewed, starting with the earliest.  The earliest studies included a 
placebo  relaxation  condition  but  not  a  placebo  biofeedback  condition.    Studies  which 
introduced a placebo biofeedback condition will then be considered, followed by studies 
comparing EMG biofeedback with cognitive treatments. The review will then move on to 
consider studies looking at the efficacy of neurofeedback.  Some studies compared EMG 
biofeedback  with  neurofeedback  and  others  looked  at  the  efficacy  of  different 
neurofeedback protocols.   
 
Studies comparing EMG biofeedback to relaxation 
Freedman  &  Papsdorf  (1976)  compared  EMG  biofeedback  with  instructed  progressive 
relaxation  as  well  as  a  placebo  „relaxation‟  group  in  which  instructions  were  given  to 
perform a set of simple exercises originally intended to help low back pain. Instructions 
were administered verbally to each group by the experimenter. Participants were informed 
about all three procedures before being randomly assigned to a group. Participants took part 
in 6 treatment sessions over 2 weeks and were asked to practice each evening at home (the 
biofeedback  group  practiced  at  home  without  the  machine).    SOL  was  measured 
subjectively  using  sleep  logs  and  objectively  by  all-night  EEG  recordings.    Volunteer 
participants, recruited from advertisements placed around a university campus and in the 
media, spent two consecutive nights in the sleep laboratory at baseline and post-treatment 
(recordings made on the 2
nd night only).  The two-month follow up consisted of subjective 
measures only. Biofeedback and relaxation both significantly improved sleep onset latency, 28 
 
but did not significantly differ from each other. A significant correlation was found between 
subjective and objective SOL suggesting good reliability.   However, it was reported that the 
baseline physiological data did not significantly correlate with the baseline SOL, suggesting 
that there may have been factors other than physiological arousal responsible for decreasing 
SOL.  Sleep-onset  times  in  the  lab  were  independently  and  blindly  re-scored  with  high 
reliability found. Freedman & Papsdorf‟s study scored relatively highly on the quality rating 
scale compared to the majority of other studies reviewed (see Table 1.1). This study was one 
of only two to receive „High‟ scores according the arbitrary rating system. 
 
Haynes et al. (1977) also found both EMG biofeedback and relaxation alone to significantly 
reduce SOL compared to a control group, and again the two treatments did not significantly 
differ from each other.  Similar to the study by Freedman & Papsdorf, participants were 
volunteers recruited via newspaper advertisements and from university. About half of the 
participants were university students and the mean age of participants was 29.3 years.  In 
this study, control group participants were told to relax but not given any further instructions 
on how to do so.  Unlike the previously described study, in which instructions were given 
verbally, recorded instructions were played to all groups which included the same rationale 
about the benefits of relaxation.  Conversation between experimenter and participants was 
kept minimal. It was reported that the two-week baseline phase in which sleep logs were 
kept was also intended to control for possible reactive effects of self-monitoring. The groups 
did not differ at baseline in terms of sleep variables. The improvements in self-report sleep 
measures seen post-intervention were maintained at 1 year, however several participants 
were lost to follow-up. A limitation of this study is that only subjective sleep measures were 
employed.  Additionally, it received a „low‟ score on the quality rating scale. Tarrier & 
Wykes  (2004),  in  their  analysis  of  randomised  controlled  trials  of  cognitive  behaviour 29 
 
therapy for schizophrenia, found evidence that studies with poorer methodology tended to 
over-estimate the positive benefits of the treatment. 
 
Coursey et al. (1980) compared EMG biofeedback to a different type of relaxation therapy, 
autogenic therapy (as described by Schultz & Luthe, 1959), as well as electrosleep therapy. 
Like the study by Haynes et al., training took place over a six week period (in comparison to 
the shorter 2 week period of the Freedman & Papsdorf study).  However, unlike Haynes et 
al.‟s study, the therapist was present throughout sessions and discussion took place about 
individual progress, home practice and any problems encountered.  The participants in this 
study were, on average, older and reported difficulties with insomnia for a longer duration 
than  in  the  two  previously  described  studies  (see  Table  1.1).    Although  the  method  of 
recruitment  is  not  described,  it  was  reported  that  participants  were  required  to  have 
previously sought help due to their insomnia, a criteria that was not required in the above 
described studies.  Participants in this study reported previously trying multiple treatments.   
 
Autogenic therapy has more of a cognitive component than the progressive relaxation used 
in  the  two  studies  described  above.    Participants  focused  on  simple,  repetitive  phrases 
suggesting feelings of warmth and heaviness e.g. “my right arm is heavy”. At the same time 
they  attended  to  the  feelings  experienced  in  the corresponding  body  part.    Electrosleep 
therapy was employed as a placebo control group to the biofeedback group, something that 
had not been done in the above described studies. Electrosleep resembled biofeedback since 
electrodes were attached to the forehead and a therapist was present, however, it did not 
involve active engagement in relaxation. Instead it involved administration of low-current 
electrical stimulation.   The daily home practice varied between groups (see Table 1.1) but 
both groups carried out the final practice before bed. A portable EMG feedback device was 30 
 
provided  for  home  practice,  something  which  wasn‟t  available  to  participants  in  the 
Freedman & Papsdorf study. This greatly increased the amount of biofeedback practice that 
participants were able to engage in (twice daily for 6 weeks at home). Daily sleep logs were 
kept  from  2-5  weeks  pre-treatment  and  for  2  weeks  post-treatment.  All-night  EEG 
recordings were made on 4 consecutive nights (out of 5 in the sleep laboratory) 1 week pre- 
and 1 month post-treatment.  Both EEG & sleep logs showed significantly reduced SOL in 
50%  (3/6)  of  biofeedback  participants,  2/6  autogenic  participants  and  none  of  the 
electrosleep  participants  with  the  biofeedback  group  showing  significantly  better 
improvement than the electrosleep group.  Since improvements were not seen in all groups, 
it seems less likely that they were due to placebo or expectation.  Objective EEG recordings 
corroborated the subjective data. It was reported that the participants who did not respond to 
treatment at all were experiencing more serious and ongoing life stress at the time of the 
study than those who did respond.  However it was also noted that this stress was not 
evident in EMG levels indicating that this stress did not seem to be interfering with sleep 
due to muscle tension. The study by Coursey et al. received a score of 42 on the rating scale, 
which lies at the lower end of the „medium‟ category. 
 
Hughes & Hughes (1978) compared EMG biofeedback with pseudo-biofeedback (a placebo 
in which false feedback was given), relaxation as well as stimulus control training.  They 
found that self-reported SOL decreased in all four groups with no significant differences 
between  groups,  including  the  pseudo-feedback  placebo  group.  The  four  groups  were 
designed  to  be  as  similar  as  possible  to  each  other.    The  biofeedback  and  pseudo-
biofeedback groups were identical except for the  actual/false feedback.  The studies by 
Freedman & Papsdorf and Haynes et al. employed a relaxation group placebo but not a 
biofeedback placebo.  Electrosleep was introduced as a placebo by Coursey et al., and whilst 31 
 
it  was  similar  in  procedure  to  EMG  biofeedback,  it  was  not  as  similar  as  the  pseudo-
feedback employed in this study, which was a strength. The relaxation group listened to 
taped instructions and the stimulus control group were given instructions during the first 
session relating to their sleep behaviour and their progress was discussed and encouraged 
during subsequent sessions.  All sessions started with a review of the previous week‟s sleep 
chart.  This  individual  review  and  discussion  may  have  been  an  important  part  of  the 
intervention, and may be comparable to the opportunity that participants in Coursey et al.‟s 
study had to discuss their progress. 
 
Daily sleep logs were kept for two weeks at baseline and again post-treatment.  The number 
of training sessions varied between groups and depended on the complexity of the treatment 
(see Table 1.1). However, participants in all groups received substantially less training than 
participants in Coursey et al.‟s study and the stimulus control training group received only 
two training sessions. Similar to participants in the above described studies, they were told 
to  apply  what  had  learned  in  the  evening  to  help  them  sleep,  although  biofeedback 
equipment  was  not  provided.  All  four  groups  showed  reduced  SOL,  but  did  not  differ 
significantly  from  each  other.  Improvements  were  maintained  at  1  year  follow-up 
(conducted by telephone), however contact was only made with 12 participants at this time. 
Like in the above studies, participants were volunteers, they  were not required to have 
sought help previously (as with Coursey et al.) and the reported duration of symptoms was 
not reported although it may have been as little as four months (see Table 1.1).  Objective 
laboratory data was not collected and the study received a „low‟ quality rating score (similar 
to Haynes et al.). 
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EMG activity was not significantly reduced and so did not seem to explain the significant 
reduction in SOL. Also, EMG scores did not significantly differ across groups indicating 
that the modest reduction that was found was not due to the effects of a particular treatment.  
Medication was ruled out as a possible confounding variable.  Hughes & Hughes suggested 
that the introduction of a bedtime routine may be a nonspecific effect of the treatments 
which  could  have  influenced  the  results.  Cognitive  activity  that  may  have  previously 
interfered with sleep-onset could have been reduced through involvement in the routines 
engaged in by participants as part of their treatment. Indeed this may be true of the other 
studies reviewed. It was also suggested that expectation of improvement could have resulted 
in less worry about insomnia.  It has been well documented that worry about insomnia 
interferes with sleep (Espie, 2002; Harvey, 2002). 
 
In a similar study, Nicassio et al. (1982) compared EMG biofeedback with pseudo-feedback 
and progressive relaxation, as well as a no-treatment control group.  The results were similar 
to those of Hughes & Hughes (1978) in that EMG biofeedback was found to be equally as 
successful as relaxation alone in improving sleep, and neither treatment was significantly 
more effective than the pseudo-feedback placebo group.  The participants in Nicassio et al‟s 
study were older and are likely to have had insomnia for considerably longer (see Table 1.1; 
however mean duration was not reported by Hughes & Hughes).  Participants in all groups 
took part in a greater (and equal) number of training sessions, and more frequent home 
practice compared to the Hughes & Hughes study. Additionally, subjective sleep log data 
was  substantiated  by  spouse/roommate  reports  however,  again  there  was  no 
polysomnographic data collected.  Again, this study scored „low‟ on the quality rating scale.  
Improvements were maintained at 6-months on follow-up. 
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EMG activity was found not to be significantly associated with SOL reduction, suggesting 
that it may not have been a reduction in physiological relaxation that was responsible for the 
reduced SOL.  Also supporting this is the fact that the false-biofeedback placebo treatment 
also  resulted  in  reduced SOL.  As  in  the  study  by  Hughes  &  Hughes,  the  placebo  was 
intended to control for expectation of improvement.  It could be that a high expectation for 
improvement may have impacted on the results of both studies. Cognitive processes may 
have had a role in the improved sleep reported.  It was suggested by Nicassio et al. that 
engaging in the treatment at bedtime could perhaps focus attention away from cognitive 
intrusions which may otherwise have delayed sleep-onset.  Perhaps the daily home practice 
aspect of the treatments is important for this reason.   
 
Neither of the studies by Nicassio et al. or Hughes & Hughes employed objective laboratory 
data unlike the studies by Freedman & Papsdorf and Coursey et al. There is evidence that 
individuals with insomnia are often inaccurate when self-reporting sleep latency, with a 
tendency  to  over-estimate  it  (Freedman  &  Papsdorf,  1976;  Monroe,  1967).    However, 
Freedman & Papsdorf reported that participants‟ estimates of SOL became more consistent 
with objective data as treatment progressed.  
 
In the previously described studies, EMG level was not found to be significantly related to 
insomnia  or  sleep  improvements  suggesting  that  learned  relaxation  may  not  have  taken 
place. VanderPlate and Eno (1983) carried out a study with the aim of further investigating 
the efficacy  and  specific  effects  of  EMG  biofeedback  for  insomnia  and  to  do  so  when 
learned  relaxation  does  in  fact  occur.  They  compared  EMG  biofeedback,  an  identical 
pseudo-biofeedback  group,  a  self-monitoring  group  and  a  waiting  list  control.    The 
treatment protocol was not sufficiently described to allow comparison with the other studies. 34 
 
The self-monitoring control was included to investigate whether the self-monitoring aspect 
of treatments alone led to improved sleep. Both the biofeedback and pseudo-biofeedback 
group reported significantly reduced SOL relative to the two controls with no significant 
difference between these groups (maintained at 2 months follow-up).  SOL in  the self-
monitoring or waiting list control groups did not improve.  Findings relating to the non-
specific effects of the placebo group are consistent with Hughes & Hughes and Nicassio et 
al.‟s studies.  However, the findings also suggest that the self-monitoring aspect of the 
interventions  is  not  responsible  for  the  improved  sleep.  Biofeedback  but  not  pseudo-
feedback was found to significantly reduce EMG levels suggesting that the participants in 
this group had actually learned to relax (Hughes & Hughes found no difference between 
these  groups  in  EMG  level  suggesting  that  this  learning  may  not  have  taken  place).  
However, no relationship was found between EMG level and insomnia.  This study provides 
further evidence that reduced SOL following biofeedback may not be due to reduced muscle 
tension.  VanderPlate and Eno suggest that expectancy may play a role. Results of this study, 
however, should be interpreted with caution.  Like many of the previously discussed studies, 
the  sample  was  small.    This  study,  however,  employed  an  all  female,  volunteer 
undergraduate  student  sample  with  relatively  mild  insomnia  compared  to  other  studies, 
therefore the results may not generalise to the wider insomnia population. The self-report 
data was not corroborated with objective laboratory data and the quality rating of this article 
was the lowest of the studies reviewed (see Table 1.1). 
 
Studies comparing EMG-biofeedback & Cognitive Treatment 
Pre-sleep  arousal  can  be  both  physiological  and  cognitive  in  nature,  and  most  likely  a 
combination of both. Morin (1993) outlines an interacting sub-systems model of insomnia in 
which  cognitive  processes  such  as  worry,  unrealistic  expectations  or  rumination  over 35 
 
possible consequences of sleep loss may become dysfunctional and result in hyperarousal 
(via  maladaptive  habits  and  their  consequences).    In  this  model,  hyperarousal  can  be 
emotional, cognitive and physiological in nature and in turn leads to further dysfunctional 
cognitions. Physiological and cognitive hyperarousal are likely to interact in both directions 
with an increase or decrease in one, similarly affecting the other. Another example of this 
interaction  is  given  by  Morin  et  al.  (2003)  who  report  that  individuals  with  insomnia 
perceive life stressors as more stressful compared to those without sleep difficulties, which 
results in increased pre-sleep arousal and poorer sleep. 
 
Sanavio  (1988)  hypothesised  that  individuals  who  experienced  either  excessive 
physiological  arousal  or  excessive  cognitive  arousal  may  benefit  from  a  treatment 
specifically addressing that type of arousal.  Sanavio compared EMG biofeedback with a 
cognitive treatment which included paradoxical intention, thought stopping and cognitive 
restructuring components.  The Pre-sleep Intrusive Cognitions Inventory (PICI; Rolletto et 
al., 1983, in Sanavio, 1988) was administered to identify individuals with either high or low 
pre-sleep cognitive arousal. Six high and six low arousal participants were then randomly 
assigned to each treatment group and a 7 day baseline was  established from sleep logs.  
Treatments  were  standardised  using  video  and  written  information  and  scripts  were 
provided for home practice. Both treatment groups reported significantly improved SOL, 
TST & sleep quality which was maintained at 3 and 12 months. However, there were no 
significant differences between treatments and neither treatment was more beneficial than 
the other for high and low cognitive arousal groups, thus not supporting the hypothesis. A 
strength of this study was that participants were referred patients reporting insomnia for a 
duration of approximately 10 years. Limitations include the use of a very small sample, the 
short treatment period and the quality rating which just made the „moderate‟ classification 36 
 
(see Table 1.1). Spouse/roommate checks showed adequate reliability with the sleep log 
data, although no polysomnography or EEG recordings were carried out.  
 
In a subsequent study, Sanavio et al. (1990) investigated the effects of three different types 
of  treatment:  EMG  biofeedback,  cognitive  treatment  (including  paradoxical  instructions, 
thought-stopping  and  cognitive-restructuring)  and  stimulus  control  therapy  (targeting 
maladaptive sleeping habits and also incorporating a progressive relaxation component). 
These treatments were compared to a waiting list control. The rationale behind stimulus 
control therapy is that poor sleep hygiene may have led to going to bed becoming associated 
with  arousal  instead  of  sleep  cues.  All  three  treatment  groups  reported  improved  SOL, 
WASO, sleep quality and restedness two months post-training. Of note is that only the 
cognitive treatment group reported significantly improved TST.  Similar to the previous 
study, there were no overall significant differences between treatments and no change was 
reported  by  controls.  These  effects  were  maintained  at  one  and  three  year  follow-up. 
Sanavio et al. chose not to restrict participants to those with only sleep-onset difficulties for 
the  reason  that  this  may  not  be  reflective  of  the  general  insomnia  population.  All 
participants were required to be clinically referred patients and to report both sleep-onset 
and  –maintenance  difficulties  with  a  duration  of  at  least  5  years.  Video  and  written 
information was used to standardise the treatments and manuals & scripts were provided for 
home practice.  Like the Sanavio (1988) study, the sample was small and no laboratory data 
was  gathered  to  corroborate  the  subjective  data,  however  spouse/room-mate  data  were 
gathered and agreement with the self-report data was high.   
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Studies comparing EMG-biofeedback & Neurofeedback 
Hauri (1978) compared three different types of biofeedback: EMG biofeedback, EMG-theta 
feedback,  and  SMR  feedback,  as  well  as  a  treatment  as  usual  (TAU)  control  with  the 
intention of investigating whether any effects were due to either non-specific effects of 
biofeedback training or to a specific biofeedback parameter.  Participants were randomly 
assigned to one of the four groups.  The EMG theta group first received EMG training 
similar  to  the  EMG  biofeedback  group  before commencing  the  theta  feedback training. 
Feedback was in the form of clicking sounds.  SMR feedback was given by a yellow light 
which varied with SMR  and a sound which indicating when SMR activity had reached a 
certain  level.  The  TAU  group  received  an  appropriate  “best  current  treatment”  e.g. 
psychotherapy, stimulus control therapy or medication. The number of training sessions 
greatly varied between participants (15-60) according to individual progress. Additionally, 
training  procedures  and  interactions  between  technicians  and  participants  were  not 
standardised  either.  Sleep  was  evaluated  in  the  laboratory  for  3  nights  pre-  and  post-
treatment. Daily sleep logs were kept throughout the training period and for 2 weeks post-
treatment.  TST and SOL significantly improved in the EMG biofeedback group according 
to subjective, home data but not lab data. The SMR group showed improved SOL in home 
data and improved SE in the lab data as well as to lengthen time in stage 2 sleep. No 
significant  improvements  in  EMG/theta  or  TAU  control.    The  EMG/theta  group  were 
reported to have been less thoroughly trained in EMG than EMG alone group, which may 
explain the differing results between these two groups. Differences between the laboratory 
and home data suggest problems with reliability or validity. Hauri suggested that individual 
differences  may  impact  on  the  method  of  biofeedback  most  likely  to  be  beneficial  i.e. 
differences  in  levels  of  psychological  or  physiological  arousal  or  sleep  spindle  activity 
during  stage  2  sleep.  When  this  was  investigated  post  hoc,  it  was  found  that  when 38 
 
appropriate biofeedback was provided (by chance due to randomisation), it was indeed more 
successful. 
 
However, it was noted by Hauri that there was some concern about there being variation 
over time in the enthusiasm held by technicians for particular therapies.  This was addressed 
by  monitoring  this  and  attempting  to  increase  enthusiasm  for  therapies  as  considered 
appropriate through discussion and the provision of reading material.  Participants in this 
study were referred patients with chronic, severe insomnia, which is a strength. However 
limitations include the lack of standardisation in treatment which was evident.  The study 
received a moderate quality rating (Table 1.1).  Also of note is that although participants did 
learn to produce more SMR in the lab, they did not become aware of any feelings associated 
with SMR activity, which was reported as frustrating. SMR feedback is a more complicated 
form of biofeedback in terms of participant understanding as well as training provision.  
 
In  a  further  study  by  Hauri  (1981),  EMG  biofeedback,  EMG/theta  feedback  and  SMR 
feedback were again compared but this time with a no-treatment group to control for change 
occurring over time, or due to life events. Interest at this time was not just in looking at 
relaxation as the end point but in trying to establish mechanisms by which change took 
place.  Participants,  of  which  some  were  referred  insomnia  patients  and  all  reporting 
symptoms  for  at  least  2  years  (Table  1.1),  were  randomly  allocated  to  groups.  
Polysomnography was carried out over 3 nights in the laboratory pre-training, immediately 
post-training and at 9 months follow up. This time, neither of the three treatment groups 
showed  any  more  improved  sleep  than the control  group  and  there  were  no  significant 
differences between the three groups.   
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Also investigated was whether the treatment each participant was randomly assigned to was 
clinically  appropriate  or  inappropriate  according  to  their  specific  type  of  insomnia  and 
whether this affected outcome. This was similar to the approach taken by Sanavio (1988). 
Both EMG and EMG/theta biofeedback was considered appropriate for individuals whose 
insomnia was thought to be due to high arousal levels. However, some individuals already 
had low arousal levels, and for these individuals, SMR training was considered appropriate. 
It was hypothesised that these individuals may have difficulties inducing sleep due to having 
a  weaker  sleep  system,  evident  in  poorly  formed  sleep  spindles,  and  that  this  may  be 
targeted by SMR training.    Unlike in Sanavio‟s (1988) study, the results indicated that only 
those  who  received  appropriate  biofeedback  showed  significantly  improved  sleep.  
Relaxation training helped those who found it difficult to relax, but those who were able to 
relax easily were more likely to be helped by SMR feedback. These results indicate that the 
effects were not likely to be due to a placebo effect. The technician carrying out the training 
was  blind  to  whether  participants  were  receiving  appropriate  or  inappropriate  feedback. 
Similar  to  the  1978  study,  the  data  indicated  that  EMG  training  alone  may  be  more 
successful than EMG/theta training and it is possible that this is due to the EMG portion of 
the training being more thorough when it was the sole type of training administered. 
 
Hauri  et  al.  (1982)  replicated  the  1981  study  because  of  identified  methodological 
shortcomings:  the  post  hoc  nature  of  the  findings  relating  to  appropriate/inappropriate  
biofeedback on outcome, and the differences in the equipment used in EMG/theta feedback 
compared with SMR feedback (i.e. auditory versus visual feedback as well as differences in 
the  way  the  equipment  was  affected  by  artifacts).    However,  both  studies  were  given 
identical moderate quality ratings (Table 1.1).  The recruitment, selection and assessment of 
participants remained the same.  However, participants were then randomly assigned to 40 
 
either a theta or SMR feedback group, with the groups being matched for sex and age. All 
participants  received  some  EMG  feedback  training  at  the  outset.    The  same  type  of 
equipment was used for both groups with a coloured light, which varied in brightness, being 
used to provide the feedback.  The same explanation was provided to participants in both 
groups and the technicians were thought to be unbiased in their expectations.  Data were 
gathered  from  2  weeks  of  home  sleep  logs  and  2  nights  in  the  laboratory  (out  of  a 
consecutive 3 nights) pre-training, immediately post-training and again 9 months later.   
 
The  results  generally  replicate  those  of  the  original  study.  The  subjective  data  showed 
improved  TST  and  SOL  in  both  the  theta  and  SMR  feedback  groups.  However,  the 
laboratory data indicated that neither of the groups had significantly improved sleep over the 
course  of  the  study  and  that  neither  theta  nor  SMR  feedback  was  significantly  more 
successful than the other. Participants were randomly allocated to groups so some may have 
received biofeedback training appropriate to their particular type of insomnia while others 
may have received a more inappropriate treatment.  Looking at the subjective sleep log data 
alone, appropriateness did not seem to be relevant with improvements being reported when 
both appropriate and inappropriate training was administered. This finding is similar to the 
findings by Sanavio (1988) which included subjective data only. However, the objective 
laboratory data indicated that when the feedback was appropriate (i.e. theta feedback was 
deemed appropriate for participants who were muscularly tense, and SMR feedback was 
deemed appropriate for those who were not), SE & SOL significantly improved.  Sleep did 
not improve when the feedback was of the inappropriate type. 
 
A limitation of this study is that the results did not all reach significance, however the low 
numbers would suggest it may not have been adequately powered.  The results add to the 41 
 
evidence that arousal levels are relevant to which type of biofeedback is likely to be most 
beneficial.  Relaxation training methods seem most suitable for those with high arousal 
levels and SMR feedback most suitable for those already able to relax sufficiently. 
 
All the studies reviewed so far were published between 1976 and 1990. However, a more 
recent study has since emerged (Cortoos et al., 2010a) and a further study was known to be 
in  press  at  the  time  of  writing  (Hammer  et  al.,  2011).  Cortoos  et  al.  investigated 
neurofeedback, although rather than focusing on frequencies associated with sleep-onset, as 
Hauri  did,  Cortoos  et  al.  decided  to  focus  on  several  frequencies  relating  to  sleep  and 
cognitive processes. This change in protocol was reported to be influenced by more recent 
research findings and theories including the neurocognitive model (Perlis et al., 1997).  The 
neurofeedback group in this study was trained to increase SMR, whilst inhibiting theta and 
high beta activity.  Also influencing this change in protocol was Cortoos et al.‟s observation 
that  research  suggests  that,  for  a  proportion  of  insomnia  patients,  treatments  targeting 
cognitive and physiological arousal does not result in substantial enough improvements in 
sleep.  A focus on cortical arousal was therefore thought to be warranted. 
 
The biofeedback training in this study varied from that of previous studies in another aspect 
also as it took place at participants‟ homes over an internet connection.  The researchers 
named this variation „tele-neurofeedback‟ and „tele-biofeeback‟. Participants were trained to 
use the equipment and attach the electrodes themselves.  Training took place according to a 
strict timetable and the therapist phoned participants prior to each session to check that there 
were no technical difficulties.  The equipment gave visual feedback as part of training. 
 
A good sleeper control group was also included in order to compare baseline sleep measures.  42 
 
Sleep  logs  were  completed  for  two  weeks  prior  to  training  and  during  training. 
Polysomnography was recorded in the sleep laboratory pre- and 2 weeks post-training.  The 
results  indicated  that  the  neurofeedback  group  was  more  successful  at  improving  sleep 
according to both objective and subjective data than the EMG biofeedback group. Both 
types of biofeedback led to decreased objective SOL, however most participants reported 
insomnia of the sleep-maintenance type. Only the neurofeedback group showed improved 
objective  TST  and  the  neurofeedback  group  showed  greater  improvement  in  objective 
WASO.  The neurofeedback group showed improvement in all subjective measures, while 
the EMG biofeedback group did not show improved sleep logs. 
 
The neurofeedback group showed greater improvements compared to the EMG biofeedback 
group.  This contrasts with the previous research findings discussed. Hauri (1981) found no 
significant differences between EMG biofeedback, EMG/theta feedback and SMR feedback 
groups.  As discussed, the neurofeedback protocol used by Cortoos et al. is different to the 
SMR training used by Hauri in previous studies, targeting cognitive processes rather than 
sleep onset. This approach had never before been used in an insomnia intervention study.  
 
Subjective and objective data indicated that the insomnia participants in this study were 
more cognitively aroused but not more physiologically aroused than the healthy  sleeper 
controls.  This  may  have  therefore  influenced  results  i.e.  that  the  intervention  targeting 
physiological arousal was less successful. All of the subjective sleep variables improved in 
the neurofeedback group only indicating that nonspecific effects of the training alone were 
not  responsible  for  the  improvements.    Previous  biofeedback  studies  took  place  in  a 
laboratory setting, often with a therapist.  It is possible that the  home setting may have 
impacted on the results.  The participants in this study were referred insomnia patients 43 
 
reporting symptoms for a minimum of 6 months.  This study scored highly on the quality 
rating scale, obtaining the highest score amongst the studies reviewed (Table 1.1).  Like all 
of the previous biofeedback studies, the small sample size may affect power.  
 
The tele-feedback procedures reduce the time commitment for participants but, obviously 
the home environment is not a controlled environment and the number of distractions or 
disruptions  experienced  by  participants  is  not  known.  Cortoos  suggested  that  further 
investigation to compare neurofeedback in the lab with tele-neurofeedback would be useful. 
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Discussion 
 
The aim of this review was to evaluate the evidence for the efficacy of biofeedback as a 
treatment for insomnia.  Twelve articles were reviewed and included articles investigating 
the  efficacy  of  EMG  biofeedback  and  various  neurofeedback  protocols.  Various 
biofeedback  procedures  were  compared  to  each  other  and  to  relaxation  and  cognitive 
therapies as well as a variety of control groups.  
 
Several studies found EMG biofeedback to significantly improve SOL but to be no more 
effective than relaxation.  This finding was reported by Freedman & Papsdorf (1976) in 
their high quality rated study employing both subjective and objective data; Haynes et al. 
(1977) in their low quality rated study which employed subjective data only; and also in 
Hughes & Hughes‟ (1978) study which also employed only subjective data and was 
rated as low quality. However participants in all three studies were relatively young 
volunteers from the general population and university campuses and the results may not 
generalise to a wider and more chronic insomnia population. Hughes & Hughes‟ study 
included a pseudo-biofeedback group as a placebo with an almost identical procedure to 
the EMG biofeedback group.  Nicassio et al. (1982) also employed a similar placebo 
group  and  the  findings  were  similar  with  EMG  biofeedback,  pseudo-feedback  and 
relaxation groups all reporting reduced subjective SOL.  Participants in Nicassio et al.‟s 
study  reported  more  chronic  insomnia  and  the  subjective  data  was  corroborated  by 
spouse/roommate reports and the participants.   VanderPlate & Eno (1983) also found 
pseudo-feedback  to  improve  subjective  SOL,  although  it  is  of  note  that  this  study 
received the lowest quality rating of those reviewed. Since these placebo groups, which 45 
 
employed  procedures  almost  identical  to  their  corresponding  EMG  biofeedback 
procedures, also reported improved (subjective) sleep, it seems likely that non-specific 
effects of the interventions are impacting on the outcome. 
 
Whilst results indicate that engaging in EMG biofeedback can lead to reduced sleep latency, 
it seems that this may not be due the intended effects of biofeedback i.e. learning how to 
reduce muscular tension or to relax by whatever means.  In general, EMG level was not 
found to be significantly related to insomnia or sleep improvements (Freedman & Papsdorf, 
1976; Haynes et al., 1977; Hughes & Hughes, 1978; Nicassio et al., 1982).  It is of note that 
these studies are roughly thirty years old, and other than the Freedman & Papsdorf study, do 
not  score  highly  on  the  modified  CTAM.    This  suggests  they  are  not  meeting  today‟s 
standards in terms of their methodological quality.   The data suggest that improvements in 
sleep  variables  may  not  have  been  due  to  learned  relaxation  occurring  but  to  some 
nonspecific  effects  of  treatment.  The  findings  of  the  studies  which  employed  pseudo-
biofeedback further implicate that non-specific effects may have impacted on the results. 
 
So what are these non-specific effects that may be influencing the results and resulting in 
improved sleep? VanderPlate & Eno (1983) included a self-monitoring control group in 
their  study  and  concluded  that  the  self-monitoring  aspect  of  the  interventions  is  not 
responsible for the improved sleep. However, the previously described limitations of this 
study should be noted. There seems to be a substantial amount of variation in protocol 
between studies e.g. in the number of treatment sessions, delivery of training and interaction 
with  the  therapist.    One  thing  they  all  have  in  common  is  daily  home  practice  before 
bedtime.  It has been suggested that this bedtime routine could be an important factor.  It is 46 
 
possible that engaging in some practice which focuses attention away from maladaptive 
cognitive processes could prevent the high arousal that might otherwise occur and interfere 
with the onset of sleep.  Expectation of improvement could also be responsible for improved 
sleep.  It has been suggested that this expectation could result in less worry about insomnia 
and  its  consequences  which  are  thought  to  play  a  part  in  the  maintenance  of  sleep 
difficulties (Espie, 2002). It is possible that the bedtime routine, expectation of improvement 
and resulting reduced worry could all play a part in reducing engagement in sleep effort, 
which can be responsible for maintaining sleep difficulties (Espie et al., 2006). 
 
Sanavio  (1988)  hypothesised  that  cognitive  treatment  may  be  more  successful  for 
individuals with high cognitive arousal impacting on their sleep and that EMG biofeedback 
may be more successful for individuals with low cognitive (and therefore physiological) 
arousal. Although sleep improvements were observed following both treatments, there were 
no significant differences between treatments and neither treatment was more beneficial 
than the other for high and low cognitive arousal groups. Perhaps a limitation of this study, 
not previously discussed is the dualistic approach to the study design.  Whilst it may be true 
that  some  individuals  experience  either  physiological  or  cognitive  pre-sleep  arousal  as 
dominant to the other, given the work by Morin (1993; et al., 2003) described above, it is 
difficult to conceptualise the possibility of treating one form of hyperarousal without also 
treating  the  other.    It  therefore  is  not  surprising  that  both  treatments  were  equally  as 
successful for both high and low cognitive arousal groups. 
 
Studies  investigating  the  efficacy  of  Neurofeedback  procedures  as  an  intervention  for 
insomnia were also reviewed. Protocols varied in the type of brain activity they targeted 
with the older studies targeting sleep onset processes (SMR and theta feedback; Hauri 1978, 47 
 
1981; Hauri et al., 1982) and more recently, Cortoos et al. (2010) introduced a protocol 
which targeted brain activity related to cognitive processing.  
 
Hauri  (1981)  found  EMG  biofeedback,  EMG/theta  feedback  and  SMR  feedback  to  be 
equally successful at improving sleep when the groups as a whole were compared. However, 
when individuals were considered post hoc, the results indicated that EMG and EMG/theta 
biofeedback was successful when participants‟ insomnia was due to high arousal and SMR 
training was successful when participants‟ insomnia was not due to high arousal but instead 
likely to be due to a weaker sleep system.  These results contrast with the findings of 
Sanavio  (1988)  who  did  not  find  support  for  an  appropriate/inappropriate  treatment 
hypothesis, although Sanavio‟s study was concerned with cognitive arousal, assessed by a 
self-report questionnaire as opposed to the more objective EMG data collected in Hauri‟s 
(1981) study.    
 
Hauri et al.‟s (1982) subsequent replication study compared theta with SMR feedback. Both 
treatment  groups  showed  some  improved  sleep  however  neither  of  the  groups  had 
significantly  improved  sleep  over  the  course  of  the  study  and  neither  protocol  was 
significantly more successful than the other. The objective, but not subjective, data provided 
further evidence to the hypothesis that particular biofeedback protocols are more appropriate 
for particular types of insomnia. Training, in which the end-point was relaxation, was more 
appropriate for those with high arousal levels and SMR feedback seemed more suitable to 
those already able to relax sufficiently.  
 
Cortoos‟  et  al.  (2010a)  found  their  neurofeedback  protocol  which  targeted  cognitive 
processing to be more successful at improving sleep than EMG biofeedback in their high 48 
 
quality rated study of clinical insomnia patients.  A similar neurofeedback protocol had 
previously been found to improve attentional processes in a non-sleep disordered sample 
(Egner & Gruzelier, 2001, 2004 as cited in Cortoos et al., 2010a). Cortoos et al.‟s study 
provides evidence that cortical arousal may influence sleep processes in some individuals. 
Indeed,  the  results  are  discussed  with  reference  to  Perlis  et  al.‟s  (1997)  neurocognitive 
model  which  suggests  that  cortical  hyperarousal  may  interfere  with  normal  information 
processing, which leads to disruptions in sleep. It is important to note that the participants in 
Cortoos  et  al.‟s  sample  did  not  appear  to  have  insomnia  caused  by  high  physiological 
arousal at bedtime.  This may, in part, explain why the EMG biofeedback training was less 
successful  in  this  study.    Indeed,  different  biofeedback  protocols  may  be  more  or  less 
suitable for different insomnia presentations as suggested by Hauri (1981) and Hauri et al.‟s 
(1982) findings.   
 
Altogether,  the  studies  reviewed  suggest  that  biofeedback  may  provide  a  promising 
treatment for insomnia patients.  Different biofeedback protocols have shown promise in 
different  studies  and  this  may  be  due  to  the  large  variation  in  procedures,  protocols, 
participant  characteristics  and  insomnia  subtypes.  There  is  evidence  that  different 
procedures targeting physiological, cognitive and cortical arousal have shown promise but 
the mechanisms driving the observed reductions in insomnia symptoms are not yet clear.  
Many of the studies reviewed are decades old and the methodological quality of several of 
the studies is low according to today‟s standards. For a time, researchers appeared to lose 
interest in biofeedback as a possible treatment for insomnia and this may have been due to 
the  complicated  and  time  consuming  procedures  as  well  as  the  fact  that  more  simple 
interventions were found to be just as effective.  However, the study by Cortoos et al. shows 
renewed interest in biofeedback as a treatment for insomnia and technological advances 49 
 
appear to be able to allow such an intervention to be more easily accessible. Certainly, more 
research in this area is warranted in order to better understand the mechanisms underlying 
the intervention and also to perhaps better understand the interaction of arousal and sleep 
processes.   
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Summary 
 
Sleepwalking and sleep terrors, known as NREM (non-rapid eye movement) parasomnias 
are a relatively un-studied group of sleep disorders. The purpose of this study was to learn 
how people with these sleep disorders respond to life stress. The aim was to investigate how 
their responses to a stressful situation compared to individuals with insomnia and good sleep. 
Thirty-eight  participants  were  recruited  from  the  general  population  and  attended  the 
University  of  Glasgow  Sleep  Centre  to  take  part.    To  measure  stress,  heart  data  was 
recorded whilst participants took part in baseline, stressor (a difficult mathematical task) and 
recovery phases.  Participants also rated how stressful they found the experience.  In general, 
group differences were not found, however this may be partly due to the small number of 
people who took part. The results indicated that the sleepwalker/sleep terror group reacted 
to stress in a similar way to good sleepers.  In general, it was the insomnia group but not the 
NREM group whose data differed from good sleepers.  However, both the insomnia and 
NREM groups exhibited a relatively higher (though not statistically significant) resting heart 
rate at baseline compared to the good sleeper group, suggesting they may be slightly more 
stressed in general. The findings indicated that further exploration is warranted which may 
have potentially important implications for the development of treatments for sleepwalking 
and sleep terrors.  
 
 
 
 
 
 59 
 
Abstract 
 
To date, there is little research into either stress reactivity or the specificity of psychological 
characteristics in particular forms of sleep disorder.  NREM parasomnias are a relatively un-
studied group of sleep disorders. The purpose of this study was to gain greater insight into 
how people with NREM parasomnias respond to „threat‟ and to life situations. In particular, 
the aim was to investigate how their responses to a  psychological stressor compared to 
individuals with insomnia and to good sleepers by measuring autonomic arousal, as well as 
subjective  appraisals  of  stress.  Baseline  levels  of  autonomic  arousal  were  intended  to 
provide insight into daytime arousal levels at the trait level.  Participants (N = 38) were 
recruited from the general population and attended the University of Glasgow Sleep Centre 
to take part.  Autonomic arousal was measured via continuous electrocardiogram (ECG) 
recordings of heart rate (HR) and cardiac vagal tone (CVT) whilst participants took part in 
baseline, stressor  (a difficult  mathematical  task) and recovery  phases.  In general,  group 
differences were not found, however this may be partly due to the small sample size and 
corresponding lack of power to detect differences.  The results indicated that the NREM 
group reacted to stress in a similar way to good sleepers.  In general, it was the insomnia 
group but not the NREM group whose data differed from good sleepers.  However, both the 
NREM  parasomnia  and  Insomnia  groups  exhibited  a  relatively  higher  (though  not 
statistically significant) resting baseline HR compared to the good sleeper group, suggesting 
a higher level of underlying sympathetic arousal. The findings of this type of study have 
potentially important implications for the development of treatment programmes for NREM 
parasomnias. However, further work needs to be done before any conclusions can be drawn.  
The study was intended as an exploratory study and the preliminary findings indicate that 
further exploration is warranted. 60 
 
Introduction 
 
Parasomnias are “undesirable physical events or experiences that occur during entry into 
sleep, within sleep or during arousals from sleep”.  The International Classification of Sleep 
Disorders,  Second  Edition  (ICSD-2)  distinguishes  between  parasomnias  associated  with 
non-REM  (non-rapid  eye  movement;  NREM)  sleep,  parasomnias  associated  with  REM 
(rapid  eye  movement)  sleep,  sleep-wake  transition  parasomnias  as  well  as  „other 
parasomnias‟ which are not classified by the other categories (American Academy of Sleep 
Medicine (AASM), 2005).  NREM parasomnias are the most common type of parasomnia 
(Wills & Garcia, 2002). 
 
There are three normal states that the nervous system can be in: wakefulness, NREM sleep 
and REM sleep.  Most parts of the nervous system are active across the three states, but in 
different  manners,  and  transitions  between  states  are  complex  processes  (Mahowald  & 
Bornemann, 2005). NREM parasomnias, also known as disorders of arousal, are incomplete 
arousals  from  slow-wave  NREM  sleep  which  result  in  behaviours  associated  with 
wakefulness.  Since arousal is incomplete, the brain is partially awake and partially remains 
in NREM sleep.   The three main NREM parasomnias are sleep terrors, sleepwalking and 
confusional arousals.  They generally occur during the first third of the night and during 
episodes behaviour can appear confused and semi-purposeful.  Individuals generally do not 
remember the events, which tend to occur no more than once per night and can last from 
seconds  to  minutes  (Vaughn  &  O‟Neil,  2007).    Confusional  arousals  involve  mental 
confusion or confusional behaviour characterised by disorientation, slow speech, diminished 
mentation,  impaired  cognitive  response  and  inappropriate  behaviour.    Sleepwalking 
episodes often begin with the individual sitting up in bed and appearing confused before 61 
 
walking  or  engaging  in  more  complex  behaviours  such  as  dressing,  or  even  driving. 
Individuals may be emotionally calm or may be agitated. Violent behaviours are more likely 
to occur if attempts are made to wake the sleepwalker.  Sleep terrors are characterised by 
intense  fear  which  is  evident  in  the  individual‟s  behaviour  and  autonomic  arousal.  
Individuals tend to suddenly sit up in bed, let out a piercing scream and can be inconsolable 
as well as unresponsive to external stimuli.  (AASM, 2005.) 
 
NREM  parasomnias  are  more  common  in  children  than  adults.    Whereas  NREM 
parasomnias  in  children  appear  to  often  be  associated  with  genetic  and  developmental 
factors,  persistence  (or  onset)  into  adolescence  or  adulthood  has  been  associated  with 
psychopathology (Kales et al., 1980a; Kales et al., 1980b; Kales et al., 1982; Gau & Soong, 
1999; Ohayon, Guilleminault & Priest, 1999).  However, many individuals with NREM 
parasomnias  do  not  present  with  significant  psychopathology  and  in  fact  show  good 
psychosocial functioning (Mahowald, 2002; Mahowald & Borneman, 2005; Schenck, Boyd 
& Mahowald, 1997). 
 
NREM parasomnias are thought to occur as a result of a complex group of priming and 
precipitating factors in those that are genetically predisposed.  NREM parasomnias seem to 
be more likely to occur in the presence of factors that deepen sleep, fragment sleep or make 
arousal  from  sleep  more  difficult.  Factors  such  as  stress,  sleep  deprivation,  medication, 
alcohol and febrile illness can affect sleep and make the occurrence of NREM parasomnias 
more likely (Pressman, 2007; Mahowald & Borneman, 2005).  It is thought that a trigger is 
also necessary for a specific event to occur.  Triggers include noise, touch, and co-existing 
sleep disorders such as sleep disordered breathing or periodic leg movements in sleep. 
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Sleep disturbance and psychopathology commonly co-occur and there is a particularly high 
comorbidity between insomnia, anxiety and depression (Morin & Ware, 1996) with sleep 
difficulties being a symptom of both anxiety and depression.  The link between insomnia 
and stress is well documented.  Stress can have the effect of increasing arousal levels which 
can make it more difficult to fall, or stay, asleep (Morin et al., 2003).  Stress and anxiety 
have also been linked to NREM parasomnias (Mahowald & Borneman, 2005; Mahowald & 
Schenck, 2005; Pressman, 2007; Ohayon, Guilleminault & Priest, 1999).  Like anxiety and 
depression, insomnia and NREM parasomnias are both psychophysiological in nature since 
they have both psychological and physical aspects.   
 
Previous research has found that individuals with insomnia show greater autonomic arousal 
compared to normal sleepers (Bonnett & Arand, 1996, 1998; Adam et al., 1986; Stepanski 
et al., 1989, 1994; Haynes et al., 1974, 1981; Monroe, 1967; Freedman & Sattler, 1982; 
Riemann  et  al.,  2010),  suggesting  insomniacs  react  more  readily  to  stressors  at  a 
physiological level.  Autonomic arousal occurs as the 'fight or flight' response and has often 
been used as a measure of stress reactivity (Boyce et al. 2001) since it is an indication of 
how an individual responds at a physiological level to stressful or threatening events.  Since 
autonomic arousal is closely related to emotion it makes sense that individual differences in 
autonomic arousal in response to stress may be linked to the development of symptoms of 
psychopathology.  Studies have found individual differences in autonomic arousal to be 
associated  with  psychopathology  in  both adults  (e.g.  Raine,  1996; Rechlin  et  al.,  1994; 
Felsten, 2002, 2004) and children (e.g. Boyce et al., 2001).  Felsten, for example, reported 
associations  between  stress  reactivity,  neuroticism  and  a  vulnerability  to  stress  and 
depressed mood.   
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Also of interest is the appraisal of stress. Morin et al. (2003) found that individuals with 
insomnia tend to appraise their lives as more stressful than good sleepers even though both 
groups reported similar levels of stressors. Clinical observations of clients presenting with  
NREM parasomnias at the Glasgow Sleep Centre suggest a tendency to appear to cope well 
with challenges and stress, although perhaps superficially.  Clinicians reported a tendency 
for such individuals to appear carefree and unperturbed with regards stressors even when an 
underlying emotional vulnerability  was evident.   This pattern of „normal‟ psychological 
functioning during wakefulness in clinical NREM parasomnia populations has also  been 
reported in the literature along with suggestions that these individuals have a capacity to 
dissociate during wakefulness (Crisp, 1996; Crisp et al., 1990). Klackenberg (1982) reported 
findings indicating that children with persistent sleepwalking tended to be more inhibited 
with  aggression  and  have  a  greater  mental  defense  against  anxiety,  whilst  being  well 
functioning in terms of popularity and behaviour.  Individuals who report low levels of 
stress  even  when  high  autonomic  arousal  is  evident  may  be  described  as  repressors.  
Weinberger et al. (1979) identified repressors as individuals with low trait anxiety but high 
defensiveness.    They  found  repressors  to  respond  to  stressful  situations  with  high 
physiological arousal suggestive of anxiety. However, they also showed a tendency to avoid 
disturbing cognitions, deny cognitive anxiety and report low trait anxiety.  Derakshan & 
Eysenck (1999) concluded from their study that repressors truly believe themselves to be 
low  in  trait  anxiety  and  that  there  may  be  avoidance  or  cognitive  biases  working  at  a 
subconscious level to inhibit awareness of anxiety. 
 
Emotional stress can affect sleep quality and can influence sleep physiology as well as 
various aspects of REM sleep e.g. dream content and recall, latency to REM sleep, and 
REM sleep duration and density (Vandekerckhaove & Cluydts, 2010).   Aspects of REM 64 
 
sleep are thought to influence the way in which sleep impacts mood the following day.  
REM sleep is thought to have an important role in overnight emotional processing and 
affects our autonomic functioning and reactivity the following day (Van der Helm & Walker, 
2009; Vandekerckhaove & Cluydts, 2010). 
 
There do not appear to be any experimental studies of stress reactivity in individuals with 
NREM  parasomnias  reported  in  the  literature.  It  was  thought  that  this  would  be  an 
interesting area to investigate, along with subjective appraisals of stress, in order to gain 
some insight into how this group responds to „threat‟ and to life situations. In addition to 
looking at how individuals react to stressors physiologically, baseline levels of autonomic 
arousal in the absence of a stressor would provide insight into daytime arousal levels as a 
trait-like  feature.    To  date,  there  is  little  research  into  either  stress  reactivity  or  the 
specificity of psychological characteristics in particular forms of sleep disorder.  This study 
is designed to make comparisons between two types of sleep disorder: NREM parasomnias 
and insomnia. 
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Aims & Hypotheses 
 
Aims 
The primary aim of this study is to investigate stress reactivity in individuals with NREM 
parasomnias by measuring autonomic arousal at baseline, in reaction to a psychological 
stressor  and  during  a  recovery  period.    A  secondary  aim  is  to  investigate  individuals‟ 
subjective reports of stress across these three phases. A NREM parasomnia group (NREM) 
will be compared to a good sleeper control group (GS) as well as an insomnia control group 
(Insomnia).    Using  another  sleep  disorder  control/comparison  group  allows  better 
discrimination between findings associated with NREM parasomnias specifically, and those 
associated with disordered sleep more generally.  An insomnia group was chosen since, like 
NREM  parasomnias,  insomnia  is  also  psychophysiological  in  nature.  The  ICSD-2 
diagnostic criteria describe psychophysiological insomnia as insomnia which is caused by 
heightened arousal and learned associations which prevent sleep (American Academy of 
Sleep Medicine, 2005). 
 
Hypotheses 
Aspects of the study are exploratory in nature and so both hypotheses and supplementary 
research questions are posed. 
(1) Baseline autonomic arousal 
a)  It is hypothesised that both NREM and Insomnia will show relatively greater 
autonomic arousal at resting baseline compared to GS. 
b)  Research  question:  Is  there  a  difference  in  autonomic  arousal  at  baseline 
between NREM and Insomnia? 
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(2) Stress reactivity 
a)  It is hypothesised that both NREM and Insomnia will show relatively greater 
stress reactivity compared to GS. 
b)  Research question: Is there a difference in stress reactivity between NREM and 
Insomnia? 
(3) Recovery 
a)  It is hypothesised that both NREM and Insomnia will show a relatively slower 
return to baseline levels of autonomic arousal compared to GS. 
b)  Research question: Is there a difference in terms of how quickly NREM and 
Insomnia return to their baseline autonomic arousal level? 
(4) Subjective stress 
a)  It is hypothesised that Insomnia will report relatively higher levels of stress than 
both GS and NREM, and that NREM will report the lowest level of stress. 
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Method 
 
Design 
The study employed a mixed design.  All participants in the independent groups, NREM, 
Insomnia or GS, completed baseline, stressor and recovery phases of the experiment, with 
autonomic arousal being measured continuously.  This latter repeated measures aspect of the 
design permitted mean values for several time points per phase to be compared. Primary 
dependent variables were: (1) autonomic arousal at resting baseline, (2) stress reactivity i.e. 
autonomic arousal in response to stress in comparison to the baseline level, (3) how quickly 
autonomic arousal returns to the baseline level, and (4) subjective, self-report stress ratings. 
Additionally,  the  study  incorporated  a  replication  of  the  baseline-stressor-recovery 
procedure in order to strengthen the study design. However the results of this replication 
have not yet been examined. Analysis of  the physiological data is a detailed and time-
consuming process, therefore, it was agreed that priority should be afforded in the first 
instance to the primary within and between group comparisons (see page 82). 
 
Inclusion and Exclusion Criteria 
Inclusion Criteria 
Participants in the NREM group were required to meet the International Classification of 
Sleep Disorders, Second Edition (ICSD-2; AASM, 2005) criteria for either Sleepwalking or 
Sleep Terrors.  To meet criteria for sleepwalking, ambulation must occur during sleep. To 
meet criteria for sleep terrors, participants must experience a sudden episode of terror during 
sleep, usually accompanied by a loud scream, autonomic arousal and behaviour associated 
with intense fear. Either disturbance must not be better explained by any other disorder or 
substance. 68 
 
Participants in the insomnia group were required to meet the ICSD-2 general criteria for 
insomnia. To meet criteria, difficulty initiating or maintaining sleep, or sleep that is non-
restorative had to be reported as well as daytime impairment related to the sleep difficulty.  
The sleep difficulty had to occur despite adequate opportunity for sleep. The full criteria for 
each disorder is outlined in Appendix 2.2. Good sleepers were required to report no current 
difficulties sleeping and to be satisfied with their current amount of sleep. All participants 
were required to be adults 17 years and over. 
 
Exclusion Criteria 
Individuals were excluded if they did not meet the inclusion criteria outlined above or if 
they  met  criteria  for  both  NREM  parasomnia  and  insomnia.  Other  exclusion  criteria 
included: evidence of other sleep disorders e.g. sleep apnoea or restless leg syndrome (RLS), 
neurological disorders e.g. narcolepsy or epilepsy, cardiac problems, pregnancy, substance 
abuse or medications which can affect autonomic arousal. Individuals with DSM based Axis 
1 psychiatric disorders were excluded if their symptoms were reported as severe and/or 
untreated.  Individuals with stable and treated symptoms were included.   
 
Sample Size/Power Calculation 
To  the  knowledge  of  the  researcher,  there  are  no  prior  studies  investigating  autonomic 
arousal  in  both  NREM  parasomnia  and  insomnia  groups.  A  recent  study  (Espie  et  al., 
unpublished  abstract)  found  statistically  significant  differences  in  HR  and  CVT  in 
individuals with insomnia (n=8) compared to normal sleepers (n=9).  A medium-large effect 
size (d = 0.75) was found for HR and a large effect size (d = 1.63) was found for CVT.  
Since this is a preliminary study, both the effect size and sample size must be estimated.  It 
was hoped that this study would provide a definitive answer of how to power future studies 69 
 
investigating stress reactivity in more than one psychophysiological sleep disordered group. 
The power calculation carried out was based on the hypothesis that a significant difference 
in stress reactivity would be found between groups. This would involve comparing the three 
groups in terms of their stress reactivity change scores i.e. the difference between autonomic 
arousal at baseline and in response to the stressor. A total sample size of 69 participants was 
calculated for a one-way analysis of variance (ANOVA) using a medium-large effect size (f 
= 0.375, equivalent to d = 0.75, Cohen, 1988; as in the study by Espie et al. described 
above), a significance level of 0.05 and standard power of 0.8.  It was therefore estimated 
that 23 participants per group should be recruited in order to detect significant differences 
between the groups. 
 
Participants 
Participant Recruitment 
Participants  were  recruited  from  the  general  population.    Recruitment  took  place  in 
conjunction with the primary investigator of a parallel study, Katherine Hooker, with whom 
the  screening  procedure  was  shared.    Participants  contacted  the  UGSC  in  response  to 
advertisements  on  the  UGSC  website,  newspaper  articles  and  posters  placed  in  public 
spaces (Appendix 2.3).   UGSC staff employed a telephone screening interview (Appendix 
2.9)  to  ascertain  whether  potential  participants  met  inclusion/exclusion  criteria.    Both 
studies were also advertised at the Glasgow Science Centre where the primary investigators 
talked to approximately 180 individuals, over 8 days, about the studies. Forty-six interested 
individuals completed a screening form.  Participants were also identified via an existing 
database held at the UGSC which has details of participants who have not been suitable for 
previous research and have agreed to be contacted for future studies, as well as through the 
parasomnia  clinic  which  is  ongoing  at  the  UGSC.    The  screening  information  of 70 
 
approximately  166  potential  participants  was  considered  for  inclusion.    Potential 
participants were excluded at this point due to the following reasons: not meeting inclusion 
criteria for any of the groups, reporting medication use or a heart condition, stating that they 
did not wish to be contacted about this part of the study or living outside of the Glasgow 
area (unless it had been noted that they still wished to be contacted).  Approximately 60 
individuals  were  contacted  by  telephone  about  participation  by  the  primary  researcher.  
Additionally,  some  good  sleeper  participants  were  recruited  by  word  of  mouth  e.g. 
individuals known to the researcher, UGSC staff and other Trainee Clinical Psychologists.   
 
Participant Numbers 
Fifty-five individuals agreed to participate, however 4 later cancelled and 9 did not attend.   
Forty-two  individuals  completed  the  experimental  procedure  however  3  of  these  were 
excluded due to equipment malfunction and one other due to current psychiatric symptoms.  
Thirty-eight  participants  were  included  in  the  analysis:  15  GS,  12  Insomnia  (ICSD-2 
General Criteria for Insomnia; AASM, 2005) and 11 NREM.  The NREM group comprised 
of  3  male  sleepwalkers,  6  individuals  reporting  sleep  terrors  (2  M,  4  F)  and  2  female 
participants reporting both sleepwalking and sleep terrors.   
 
Measures 
Measures of Emotional Functioning and Psychopathology 
Depression Anxiety Stress Scales (DASS) 
The DASS-21 (Appendix 2.4) was administered to provide information at a symptom 
level in order to describe the groups. The DASS-21 is a short form of  Lovibond & 
Lovibond‟s  (1995)  42-item  self  report  questionnaire  which  is  a  reliable  and  valid 
measure of the severity of symptoms of Depression, Anxiety and Stress.  Each of the 71 
 
three scales of the DASS-21 contain seven items consisting of a statement relating to a 
symptom and respondents are asked to indicate how much each statement applied to 
them over the past week on a scale of 0-3. Scores are summed separately for depression, 
anxiety and stress. In an independent study, Henry & Crawford (2005) found the DASS-
21 to have adequate construct validity and each scale to have high reliability (Cronbach‟s 
alpha was 0.88 for Depression, 0.82 for Anxiety, and 0.90 for Stress).  The DASS was 
selected  over  other  measures  because  of  its  dimensional  nature,  which  reflects  the 
occurrence  of  symptoms  in  the  general  population,  and  because  it  provides  separate 
scores for depression, anxiety and stress.  The DASS-21 was chosen over the longer 
version due to its shorter administration time. 
 
The Mini-International Neuropsychiatric Interview (M.I.N.I.)  
The  M.I.N.I  version  5.0.0  (Sheehan  et  al.,  1998)  is  a  short,  structured  psychiatric 
diagnostic interview which has been validated against the Structured Clinical Interview 
for DSM diagnoses (SCID-P) and the Composite International Diagnostic Interview for 
ICD-10 (CIDI) as well as against expert opinion. The M.I.N.I was administered when 
possible psychopathology was indicated during the screening interview or by the DASS-
21. 
 
Sleep Measures 
Pittsburgh Sleep Quality Index (PSQI) 
Quantitative measure of sleep disturbance. 
The  PSQI  (Appendix  2.5;  Buysse  et  al.,  1989)  was  administered  to  confirm  group 
allocation and to provide a quantitative measure of sleep disturbance in order to describe 
participants‟ quality of sleep. The PSQI is a reliable and valid self-rated questionnaire 72 
 
designed to provide a standardised measure of sleep quality and to discriminate between 
good and poor sleepers. There are 19 self-rated questions (as well as an additional 5 
questions rated by a bed partner which were not used in this study), which are grouped 
into 7 component scores and then summed to obtain a global PSQI score. Higher scores 
indicate poorer sleep quality. Buysse et al. report that the PSQI has adequate validity and 
test-retest reliability and that the seven component scores have a high degree of internal 
consistency. Backhaus et al. (2002) investigated the psychometric properties of the PSQI 
for primary insomnia. High test-retest reliability for the overall PSQI global score was 
found (r = 0.87) as well as good internal consistency (Cronbach‟s alpha = 0.85) and good 
validity with high correlations found between PSQI and sleep log data.  
 
Sleep Condition Indicator (SCI)  
The  SCI  (Appendix  2.6)  is  a  measure  developed  at  the  UGSC  which  is  based  on 
proposed  DSM-5  criteria  (http://www.dsm5.org/ProposedRevision/Pages/proposed 
revision.aspx?rid=65) for a sleep disorder.  Participants are asked to report on the pattern, 
quality, impact and their concern about their sleep over the past month as well as their 
history of sleep problems. Psychometric data showing good internal consistency has been 
obtained based on 11,129 individuals from the general population (Cronbach‟s alpha = 
0.89; Espie, Kyle et al., in preparation). 
 
Impact of Poor Sleep  
The  Impact  of  Poor  Sleep  questionnaire  (Appendix  2.7),  developed  at  the  UGSC, 
contains items which inquire about the extent that poor sleep has affected six areas of 
daily  functioning.    These  areas  are  based  on  the  proposed  daytime  impact  areas  of 73 
 
Insomnia Disorder in DSM-5, the proposed revision of DSM-IV (American Psychiatric 
Association, 2010).  
 
Autonomic Arousal 
Autonomic  arousal  was  measured  by  recording  and  analyzing  continuous 
electrocardiography  (ECG)  output  using  the  Neuroscope  method  (Little  et  al.,  1999), 
yielding heart rate (HR; beats per minute; bpm) and the non-invasive index of cardiac vagal 
tone  (CVT),  the  Linear  Vagal  Scale  (LVS;  Julu,  1992).  HR  is  continually  under  the 
influence of both sympathetic and parasympathetic activity, each having an antagonistic but 
complementary  influence  (Sherwood,  2010).    Sympathetic  activity  has  the  effect  of 
quickening HR while parasympathetic (vagal) tone slows it down.  Vagal tone affects HR 
more quickly (within one heart beat) than sympathetic activity, thus it is vagal tone which is 
responsible for rapid changes in HR (Little et al., 1999).  HR and CVT were recorded 
continuously throughout all phases of the experimental procedure.  Average values were 
then calculated for each one-minute period of the experimental procedure.  
 
Visual-analogue Stress Scale 
A self-report measure of stress was employed at several points throughout the experimental 
procedure to investigate participants‟ subjective experience of stress.  Each time the stress 
scale was administered, participants were asked to rate how they felt during the previous 
few minutes using a visual-analogue scale ranging from 0 (very calm) to 10 (very stressed) 
(Appendix  2.8).    The  visual  analogue  scale  has  been  shown  to  be  a  valid  measure  of 
perceived stress when compared to scores on the Perceived Stress Scale (PSS; Cohen et al., 
1983), a validated measure, in 360 individuals (Lesage & Berjot, 2011). 74 
 
The Scottish Index of Multiple Deprivation (SIMD) 
The SIMD (The Scottish Government, 2009) was employed as a measure of socio-economic 
status.  It provides a relative measure of deprivation by ranking small geographical areas 
(data  zones)  based  on  the  domains  of:  income,  employment,  crime,  education,  health, 
housing and access.  SIMD quintile scores were obtained using participants‟ postcodes.  
SIMD Quintile 1 represents the most deprived fifth of the data and Quintile 5 the least 
deprived fifth of the data.   
 
Experimental Procedures 
As part of the screening procedure (discussed in the Participant Recruitment section above), 
participants were screened using a screening interview (Appendix 2.9), and completed a 
battery  of  4  questionnaires:  The  DASS-21,  PSQI,  SCI  and  Impact  of  Poor  Sleep 
questionnaire. Participants were invited to attend the University of Glasgow Sleep Centre 
(UGSC) to take part in the study.  On arrival it was ensured that participants were familiar 
with the participant information sheet (Appendix 2.10) which provided information about 
e.g.  the  procedure,  right  to  withdraw  and  confidentiality.  Consent  was  also  obtained 
(Appendix 2.11).  The M.I.N.I version 5.0.0 was administered to screen for DSM-based 
Axis  1  disorders  when  possible  psychopathology  was  indicated  during  the  screening 
interview or by the DASS-21. 
 
The same bedroom at the UGSC was used each time which was quiet with standardised 
temperature and light level to ensure calm, pleasant surroundings.  Due to access issues and 
time constraints, it was not possible for all participants to attend within a similar time period 
to overcome time of day as a possible confounding variable.  
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Four  adhesive-backed,  Ambu  wet  gel  disposable  ECG  electrodes,  with  popper  lead 
connections, were used per person and attached according to UGSC standard operational 
procedure. Skin was first prepared using an alcohol-based wipe and an abrasive pad in order 
to ensure a good connection.  One electrode was placed just below the right clavicle and 
another on the left torso, above the waist, in order to record activity diagonally across the 
body.  The ground and reference electrodes were placed side by side just below the left 
clavicle.  Each electrode was attached to the Lifelines Trackit Ambulatory EEG recorder, 
with a poly patient connector unit add on, by a cable. The positioning of three of the four 
electrodes can be observed in Figure 2.1.  
 
Figure 2.1: Positioning of Three of Four ECG Electrodes 
 
 
Participants were then directed to the bed where they were asked to lie in a prone position 
with their head and shoulders supported by pillows so that they could comfortably view a 
computer screen.   Body movements can affect the measures therefore participants were 
asked to remain as still as possible throughout the procedure and it was important that no 
postural muscles were engaged. The computer screen was positioned a set distance from the 
participant on a specially designed metal stand.  The participants‟ dominant hand rested so 
that they could comfortably access the response button pad. The experimental set-up is 
illustrated in Figure 2.2.  76 
 
Figure 2.2: Experimental Set-up 
 
 
Participants  were  provided  with  verbal  instructions  (Appendix  2.12)  which  included 
requesting that they remain as still as possible throughout, other than pushing the response 
buttons on the response button pad.  The researcher then left the bedroom and remained in 
the control room throughout the procedure.  A microphone system allowed audio contact 
between the bedroom and the control room. Stimuli were presented visually on the monitor 
and  participants  responded  using  a  button  press  with  four  fingers  to  move  through  the 
experiment and to answer multiple choice questions. A short training phase was initially 
presented  to  allow  participants  to  practice  using  the  response  buttons.  The  diagram 
presented to aid training is illustrated in Appendix 2.13.  Only when all four training items 
had been responded to correctly was it possible to proceed.  The experimental procedure 
included a baseline, stressor, and recovery phase, before a break period and then repetition 
of the three phases. Appropriate instructions were presented visually along with the stimuli 77 
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and frequent prompts were provided to instruct participants to press a button in order to 
move on to the next screen. The stress scale was administered prior to the first baseline 
phase and again following the completion of each subsequent phase.  Participants responded 
verbally to the visual-analogue scale and their responses were noted by the researcher in the 
control room. Vocal responses would be likely to affect the ECG data, however the stress 
scale responses took place before and after the experimental phases.  The break provided 
participants a chance to move about.  Participants were able to choose the length of the 
break and were instructed to press a button when they were ready to commence the second 
half. On completion of all phases, participants were asked to rate their overall stress as well 
as how well they thought they had performed in the stressor phases on a visual-analogue 
scale of 0 – 10. The order of phases and stress scales is illustrated in Figure 2.3. 
 
Figure 2.3: Order of Experimental Phases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Baseline and Recovery Phases 
Each baseline and recovery phase consisted of a piece of classical music [e.g. Piano Sonata 
No.  14  „Moonlight  Sonata‟  (Beethoven);  Piano  Concerto  No.  2  (Shostakovich)]  which 
played for five minutes while a picture was displayed on the screen for the same duration.  
Participants were instructed to listen to the music while looking at the image on the screen.  78 
 
A different image and piece of classical music was used for each of the four phases, each 
chosen for their intended relaxing properties.  A selection of images and pieces of music 
were sourced by the researcher and rated for their relaxing properties by both the researcher 
and another Trainee Clinical Psychologist, who was not involved with the study, as part of 
the selection procedure. The selected pictures are presented in Appendix 2.14.  
 
Stressor Phase 
Participants were presented with a series of multiple choice questions and were asked to 
read each question and respond with the appropriate response button. They were informed 
that their responses would be timed and that their task was to answer as many questions 
correctly as they could, as quickly as possible.  The questions were adapted from foundation 
and general level standard grade mathematics past papers (SQA, 2010).  Questions were 
selected  which  could  be  easily  adapted  to  a  multiple  choice  format  with  four  response 
options. See Appendix 2.15 for examples of the questions used.  Several steps were taken to 
increase  the  „stress‟  of  the  task.    A  loud  ticking  sound  was  created  by  recording  a 
metronome and this was played throughout the stressor phase with the aim of heightening 
the sense of time pressure.  Following each response, participants were told if they were 
correct or incorrect with a large „tick‟ or „cross‟ being displayed.  If they did not respond 
prior to the time limit (either 20 or 30 seconds per question) then participants were informed 
they were out of time and too slow (Appendix 2.16). There were 24 questions in each 
stressor  phase  and  the  time  taken  to  complete  this  phase  depended  on  the  speed  of 
responding and ranged from about 5 to about 9 minutes.  Each question needed to be either 
responded to or reach „time out‟ to complete the phase. 
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Experimental Paradigm Development 
Stimulus presentation software, SuperLab (Cedrus Corporation, San Pedro, CA), was used 
to programme the computer to run the experiment.   To help establish whether the stimuli 
were likely to induce the desired stress response, five volunteer participants took part in the 
development phase which involved completing the experimental procedure.  The aim was 
that the task level should be considered difficult and the success rate neither too high (not 
stressful) nor too low (participants may give up).  Verbal feedback from these participants 
as well as their subjective stress and test score data (Table 2.1) validated the experimental 
procedure, suggesting that the procedure was experienced as stressful and that the questions 
were set at a suitable difficulty level.  It was reported that the „ticking‟ sound was perceived 
as increasing the stress experienced and two of the participants commented that they were 
worried that I would be able to see that they had performed poorly.   No changes were made 
to the protocol following this phase, other than adjusting the volume on the loudspeakers. 
 
Table 2.1 Data from Experimental Paradigm Development Phase 
  Subjective Stress Rating (0 – 10)  How 
well do 
you 
think 
you 
did? 
(0-10) 
% correct 
responses 
during 
stressor task 
  Part A  Part B   
Particip-
ant 
Initial 
Stress 
 
After 
B 
 
After 
S 
 
After 
R 
 
After 
B 
 
After 
S 
 
After 
R 
Overall 
Stress 
Part 
A 
Part 
B 
A  3  2  7  3  1  7  4  7  2  54.2  66.7 
B  8  8  8  7  6  7  6  8  5  37.5  63.0 
C  1  1  10  1  2  5  2  5  3  -  40.7 
D  1  0  7  1  3  8  2  5  5  54.2  51.9 
E  2  1  6  2  1  7  2  4  6  54.2  48.2 
Mean  3  2  8  3  3  7  3  6  4  50.0  54.1 
Note: B: Baseline phase; S:  Stressor phase; R: Recovery phase 
 
ECG Recording and Data Extraction 
The ECG data were recorded using a multi-channel recorder (Trackit, Lifelines Ltd, UK) 
according to UGSC standard operational procedure. One channel recorded continuous ECG 80 
 
Notes:  
  The R wave is the tall peak 
and  the  RR  interval  is  the 
distance between two peaks. 
 
  This image was created by 
taking a photograph of the 
computer screen.  Although 
it appears that the x axis is 
rising, this is in fact only due 
to the convex nature of the 
screen. 
 
waveform  data,  while  a second  recorded the  timing  pulse  provided  by  SuperLab.    The 
recorded data were in the form of EDF (European Data Format) files, which is a standard 
file format for medical time series data. The experiment had been programmed so that a 
timing pulse would fire at the beginning and end of each baseline, stressor and recovery 
phase to mark those time points in the continuous output.  Times were also noted by hand 
by the researcher who could hear, from the control room, each phase begin and end due to 
the sound (either music or metronome) that accompanied each phase.  Spike2 software 
(Cambridge Electronic Design Limited, Cambridge) was used to establish the start time of 
each ECG recording as well as the start and finish times of each phase, as marked by the 
pulses.  
 
HR and CVT were extracted from the EDF data files using Neuroscope software (Medifit 
Instruments Ltd, London). For each participant, a template was selected of a 50 – 100 ms 
section round a QRS complex (Figure 2.4). The program used that template to identify each 
R  wave  throughout  the  recording  allowing  the  RR  intervals  to  be  determined.  The  RR 
interval is the measure of the distance between two QRS complexes in an ECG. HR and 
CVT were calculated from the RR intervals and saved in a VGS file. 
Figure 2.4: RR Interval 
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A second Neuroscope program displayed content of the VGS file which allowed visual 
inspection of the continuous data for HR and CVT (Figures 2.5 & 2.6) in the form of a 
tachogram where each point corresponds to a heart beat. Mean HR and CVT could then be 
calculated for specified time periods.  
Figure 2.5: Baseline/Stressor Portion of an ECG Output: HR (upper) and CVT (lower) 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: Stressor/Recovery Portion of an ECG Output: HR (upper) and CVT (lower) 
 
 
 
 
 
 
 
 
1  2 
2
2 
1 
Notes:   
 
  The x axis represents 
time (one point per 
heart beat). 
 
  1 marks the end of the 
baseline phase. 
 
  2 marks the beginning 
of the stressor phase.   
 
  This image was 
created by taking a 
photograph of the 
computer screen.  
Although it appears 
that the x axis is 
rising, this is in fact 
only due to the 
convex nature of the 
screen. 
Notes:   
 
  The x axis represents 
time (one point per 
heart beat). 
 
  1 marks the end of the 
stressor phase. 
 
  2 marks the beginning 
of the recovery phase.   
 
  This image was created 
by taking a photograph 
of the computer screen.  
Although it appears 
that the x axis is rising, 
this is in fact only due 
to the convex nature of 
the screen. 
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Artifacts in the ECG output were visible for a small number of participants. These may be 
caused, for example, by participant movement.  Suspected artifacts were discussed with a 
Clinical Scientist at the UGSC to ensure correct differentiation between artifacts and natural 
anomalies in the output.  Artifacts were removed manually using the computer program 
(Figure 2.7). 
 
Figure 2.7: Removal of Two Artifacts: Before (left) and After (right) 
 
 
 
 
 
 
 
 
Using cursors, one minute time intervals were selected by hand for each minute of baseline, 
stressor and recovery phase data.  Mean HR and CVT could then be calculated for each 
minute selected. Due to time constraints and the quantity of data involved, part A of the 
experimental procedure only has been analysed at this time.  A repetition design was used in 
order to strengthen the study.  The rationale was that if effects were found on analysis of 
data from part A, then the data from part B (the repetition) could be analysed at a later date.  
Thus, the baseline, stressor and recovery phases discussed from this point will refer to part 
A of the procedure only. Due to the length of the stressor phase varying from participant to 
participant, the first five minutes only of the stressor data have been used in the analysis. 
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Data Analysis 
Demographic and procedural variables were investigated as possible confounding factors 
which would be introduced as covariates in the analysis if appropriate. Mean HR and CVT 
for consecutive one minute periods during each experimental phase was calculated in order 
to test the hypotheses. These data were initially plotted on line graphs in order to inspect the 
data visually and standard error bars were drawn to look at variability. In order to establish 
the  appropriateness  of  parametric  tests,  the  distribution  and  variance  of  the  data  were 
explored. To investigate normality, the data were inspected visually using histograms, and 
values of kurtosis and skewness were calculated and converted to z scores to establish their 
significance. The results indicated that the HR data were approximately normally distributed, 
however the CVT data did not approximate a normal distribution. The results of Levene‟s 
tests (Appendix 2.17) indicated that homogeneity of variance could be assumed for both HR 
and CVT data.  In light of these findings, the decision was made to use parametric tests to 
investigate the HR data (since the assumptions of normality and homogeneity of variance 
were both upheld) and non-parametric equivalent tests to investigate the CVT data since this 
data did not approximate a normal distribution. 
 
Because this is an exploratory study with specific hypotheses, the decision was made to first 
use independent t tests (parametric) and Mann-Whitney tests (non-parametric) to compare 
groups in order to reduce the risk of making a type II error. Where significant results were 
found, Bonferroni corrections were subsequently employed to reduce the risk of type I error 
due to multiple comparisons. Where significant results were still found, it was proposed that 
an  appropriate  ANOVA  (parametric)  or  Kruskal-Wallis  test  (non-parametric)  would  be 
carried out in order to take a conservative approach and further protect against type I errors. 84 
 
Effect size for Cohen‟s 
d: 
Small:   0.2 
Medium:   0.5 
Large:   0.8 
 
If results remained significant then any confounding or explanatory variables to do with 
demographic or procedural factors would be introduced as a covariate.  However, this would 
only be possible with the parametric analyses. 
 
An area under the curve (AUC) analysis was also carried out to further investigate the stress 
reactivity hypothesis. AUC is a set of mathematical equations which can be used to measure 
change with reference to the baseline. AUC incorporates both information about the size of 
responses as well as information about change over time and is a reliable measure of change. 
Change scores incorporate data from just two data points.  However, with AUC, time series 
data across the stressor phase could be included in the analysis in order to emphasize change 
over time. AUC is a more sensitive measure of change, and its use was selected for this 
reason (Fekedulegn et al., 2007). This extra sensitivity is particularly relevant to the HR and 
CVT  data  which  typically  is  not  expected  to  vary  a  great  deal  in  magnitude  between 
participants.  Figure 2.10 (page 94) further illustrates AUC. 
 
Effect sizes (Cohen‟s d) were also calculated, using Cohen‟s 
(1988)  effect  size  conventions,  in  order  to  provide  an 
objective, standardised measure of the size of effects.  This 
enables  the  direct  comparison  of  different  variables  within 
this study as well as the comparison of results with other existing or future studies.   
 
Ethical Approval 
Ethical approval was granted by the West of Scotland Research Ethics Service (Appendix 
2.18)  and  Management  approval  by  NHS  Greater  Glasgow  and  Clyde  Research  and 
Development service in November 2010. 85 
 
Results 
 
Demographic and Procedural Variables 
The age and gender of participants is described in Table 2.2 (a). In the general population, 
insomnia occurs more frequently in women than men with prevalence increasing with age 
(Ohayon, 2002).  The prevalence of sleepwalking and sleep terrors is thought to decrease 
with age with similar prevalence rates in both men and women (Ohayon et al., 1999). On 
visual inspection of the demographic data, the age and gender of participants was found to 
be in line with what would be expected, given the prevalence rates of insomnia and NREM 
parasomnias  in  the  general  population.    On  further  analysis  it  was  found  that  age 
significantly differed according to group membership [H(2) = 11.98, p = 0.001].  Follow-up 
Mann-Whitney  U  tests  were  carried  out  and  a  Bonferroni  correction  applied  (0.05/3  = 
0.017). The NREM group significantly differed in age from both the GS (U = 36.50, z = -
2.39, p = 0.008) and the Insomnia groups (U = 14.50, z = -3.17, p = 0.001). The Insomnia 
and GS groups did not differ significantly at the 0.017 level (U = 56.50, z = -1.64, p = 0.05).  
Gender was not found to significantly differ according to group membership [χ
2 (2) = 1.54, 
p = 0.50], therefore, it was decided that, if appropriate, age alone would be introduced as a 
covariate. 
 
The percentage of participants in each group who fell into each SIMD quintile are outlined 
in  Table  2.2  (b).    A  Kruskal-Wallis  test  indicated  that  SIMD  quintile  scores  did  not 
significantly differ across groups [H (2) = 3.52, p = 0.17].  Time of day of participation, 
participant perception of how well they thought they performed in the stressor phase as well 
as the percentage of correct responses actually obtained were also investigated (Appendix  86 
 
2.19).  These factors were not found to differ significantly across groups  and so would 
therefore not be introduced as covariates in the analysis. 
 
Table 2.2: (a) Age and Gender of Participants, (b) SIMD Quintile Data and 
(c) Summary of Questionnaire Data  
 
(a)  GS  Insomnia  NREM 
n  15  12  11 
Mean age (SD)  37.53 (14.05)  48.25 (15.85)  26.18 (7.55) 
Min – max age  22 - 68  21 - 68  17 - 45 
% Male (n)  46.7% (7)  25.0% (3)  45.5% (5) 
% Female (n)  53.3% (8)  75.0% (9)  54.5% (6) 
(b)  %  n  %  n  %  n 
SIMD Quintile 1   13.3%  2  16.7%  2  36.4%  4 
SIMD Quintile 2   13.3%  2  25.0%  3  18.2%  2 
SIMD Quintile 3  26.7%  4  8.3%  1  9.1%  1 
SIMD Quintile 4  6.7%  1  16.7%  2  27.3%  3 
SIMD Quintile 5  40.0%  6  33.3%  4  9.1%  1 
(c)  M  SD  M  SD  M  SD 
PSQI Global Score  3.87  1.85  11.67  3.85  5.45  1.97 
DASS Depression  1.47  1.92  11.67  6.92  7.09  6.60 
DASS Anxiety  0.80  1.47  6.17  4.55  5.27  4.92 
DASS Stress  4.53  5.58  16.00  8.27  12.36  7.27 
SCI Score  3.80  3.76  22.00  6.92  15.64  4.03 
Impact of Poor Sleep Score  2.47  3.38  13.42  5.88  12.36  5.7 
 
Questionnaire Data 
The PSQI data confirmed group allocation with the Insomnia group, as expected, scoring 
highest, indicating poorer sleep quality.  A significance difference in the PSQI global score 
was found across groups [H(2) = 23.95, p < 0.001]. The Insomnia group scored significantly 
higher on the PSQI Global Score compared to both the GS group (U = 1.00, z = -4.36, p < 
0.001) and the NREM group (U = 6.50, z = -3.68, p < 0.001).  The NREM and the GS 87 
 
groups were not found to significantly differ in PSQI global score (U = 47.00, z = -1.87, p = 
0.07) although the good sleepers tended to receive the lowest scores, indicating better sleep 
quality.  Administration of the DASS-21 indicated that that depression, anxiety and stress 
were experienced to a greater degree in the Insomnia and NREM groups than the GS group, 
with the Insomnia group receiving the highest mean score for all three. Symptoms of stress 
and  depression  appear  to  be  experienced  to  a  greater  degree  by  all  three  groups  than 
symptoms of anxiety. 
 
The  SCI  data  indicated  that  the  groups  differed  significantly  in  their  report  of  pattern, 
quality, impact and concern about sleep [F(2, 35) = 45.73, p < 0.001].  The Insomnia group 
scored significantly higher on the SCI than both the GS (p < 0.001) and NREM (p = 0.12) 
groups.  The NREM group also scored significantly higher than the GS group (p < 0.001). A 
significant difference in the Impact of Poor Sleep questionnaire score was found between 
groups [F(2, 35) = 20.03, p < 0.001].  The Insomnia group reported a significantly greater 
impact on daily functioning than the GS group (p < 0.001) but not the NREM group (p = 
0.87).  The NREM group reported a significantly greater impact on daily functioning than 
the GS group.  
 
ECG Data 
The ECG data for HR and CVT were plotted as line graphs and with standard error bars 
(Figures 2.8 and 2.9).  Large standard error bars indicated that there was a lot of variability 
in the data.  Boxplots were created in order to further investigate this variability (Appendix 
2.20) and participants with extreme values in their data were identified.  The ECG visual 
output of these individuals was then re-examined with a Clinical Scientist at the UGSC to 
check for abnormalities or artifacts that may explain these values, however none were found.  88 
 
Line graphs were then produced of these individuals‟ data to investigate whether the pattern 
of their data was typical of the group. The CVT data of three individuals showed an unusual 
pattern compared to the rest of the group and a description of these individuals is provided 
(Appendix 2.21). 
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Figure2.8: Mean Heart Rate over Consecutive One-minute Periods throughout the 
Experimental Procedure: Standard Error Bars (+/- 2 SE) Displayed Below 
 
 
Baseline  Recovery  Stressor 
Notes:   
 
  Each point on the x 
axis represents a one-
minute time period. 
 
  B: Baseline             
S: Stressor              
R: Recovery 
 
  Due to the variation 
in time taken by 
participants to 
complete the stressor 
phase, the first 5 
minutes only of this 
phase are 
represented. 
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Figure2.9: Mean Cardiac Vagal Tone over Consecutive One-minute Periods throughout the 
Experimental Procedure: Standard Error Bars (+/- 2 SE) Displayed Below 
 
 
 
Baseline  Recovery  Stressor 
Notes:   
 
  Each point on the x 
axis represents a one-
minute time period. 
 
  B: Baseline             
S: Stressor              
R: Recovery 
 
  Due to the variation 
in time taken by 
participants to 
complete the stressor 
phase, the first 5 
minutes only of this 
phase are 
represented. 
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Baseline Autonomic Arousal 
Baseline HR 
It was hypothesised that both the NREM and Insomnia groups would show relatively greater 
arousal and therefore relatively higher HR at resting baseline in comparison to good sleepers. 
Whether  there  was  a  difference  in  HR  between  the  NREM  and  Insomnia  groups  had 
remained a research question. 
 
Visual inspection of the data (Figure 2.8, p89) showed mean HR of all groups remained 
fairly stable throughout the baseline phase (B). As expected both the NREM and Insomnia 
groups showed relatively higher resting baseline HR throughout B compared to GS. There 
did not appear to be a difference between NREM and Insomnia groups. Means and standard 
deviations for HR for each minute of B are presented in Table 2.3.  
 
Table 2.3: Mean HR (bpm) of each One-minute Period of the Baseline Phase (B) 
 
 
Note: B1 = 1
st minute; B2 = 2
nd minute etc. 
 
Independent t-tests were carried out to investigate differences in mean baseline HR (using 
the grand mean of B1 – B5) between groups. On average, participants in the NREM group 
(M = 65.72, SD = 6.06) had a higher baseline HR compared to good sleepers (M = 62.76, 
SD = 10.79). This difference was not significant [t (24) = 0.82, p = 0.42; Cohen‟s d = 0.34, 
representing a small-medium effect size].  The NREM group (M = 65.72, SD = 6.06) had a 
similar baseline HR to the Insomnia group (M = 65.51, SD = 7.44), the difference being 
    B1  B2  B3  B4  B5 
Group  n  M  SD  M  SD  M  SD  M  SD  M  SD 
GS  15  62.36  11.28  62.56  19.69  62.96  11.59  62.65  10.49  63.27  10.30 
Insomnia  12  64.66  7.73  65.03  6.71  66.06  7.77  65.93  8.17  65.87  7.36 
NREM   11  65.06  6.13  64.96  5.56  66.05  6.41  66.24  6.24  66.29  6.50 92 
 
non-significant [t (21) = 0.07, p = 0.94; Cohen‟s d = 0.03, representing a very small effect 
size]. On average, participants in the Insomnia group (M = 65.51, SD = 7.44) had a higher 
baseline HR compared to good sleepers (M = 62.76, SD = 10.79) but again, the difference 
was not significant [t (25) = 0.75, p = 0.46; Cohen‟s d = 0.30, representing a small effect 
size].  Since  no  significant  differences  were  found,  the  planned  mixed  between-within 
subjects analysis of variance was not carried out on the baseline HR data.  
 
Baseline CVT 
It was hypothesised that both the NREM and Insomnia groups would show relatively greater 
arousal  and  therefore  relatively  lower  CVT  at  resting  baseline  in  comparison  to  good 
sleepers. Whether there was a difference in CVT between the NREM and Insomnia groups 
had remained a research question. 
 
Visual inspection of the data (Figure 2.9, p90) suggested that for the NREM and GS groups, 
CVT decreased across the baseline period with the NREM group showing the highest CVT 
suggesting this group to be least aroused. The Insomnia group, however, showed stable and 
lower CVT across the baseline phase suggesting that this group showed greater arousal. 
Means and standard deviations for CVT for each minute of B are presented in Table 2.4.  
 
Table 2.4: Mean CVT (LVS) of each One-minute Period of Baseline Phase (B) 
 
 
Note: B1 = 1
st minute; B2 = 2
nd minute etc. 
 
    B1  B2  B3  B4  B5 
Group  n  M  SD  M  SD  M  SD  M  SD  M  SD 
GS  15  10.52  6.85  9.46  5.24  8.45  5.38  9.18  6.59  9.10  5.61 
Insomnia  12  6.10  4.01  6.31  4.13  5.49  2.70  5.55  3.36  6.00  3.75 
NREM   12  13.57  9.71  12.84  8.55  11.33  6.39  10.61  6.52  11.62  7.19 93 
 
Mann-Whitney U tests were carried out to investigate differences in mean baseline CVT 
(using the grand mean of B1 – B5) between groups. Baseline CVT in the NREM group 
(Mdn = 10.47) was not significantly higher than the GS group (Mdn = 8.61; U = 64.00, z = -
0.96, p = 0.36; Cohen‟s d = -0.38, representing a small-medium effect size.  Baseline CVT 
in the NREM group (Mdn = 10.47) was significantly higher than the Insomnia group (Mdn 
= 5.47) at the 0.017 level (U = 27.00, z = -2.4, p = 0.016; Cohen‟s d = -1.16, representing a 
very large effect size.  A Bonferroni correction had been subsequently applied to adjust the 
alpha level to 0.017 (0.05/3) since significance was found at the 0.05 level and there had 
been three planned comparisons.   Baseline CVT in GS (Mdn = 8.61) was not significantly 
higher than Insomnia (Mdn = 5.47; U = 58.00, z = -1.56, p = 0.126; Cohen‟s d = -0.63, 
representing a medium to large effect size.  Since a significant difference was found, a 
Kruskal-Wallis Test was carried out on the baseline CVT data and a significant result was 
found [H(2) = 5.93, p = 0.047].  
 
The  effect  sizes  calculated  for  group  interactions  of  baseline  autonomic  arousal  are 
presented in Appendix 2.23.  
 
Stress Reactivity 
It was hypothesised that both the NREM and Insomnia groups would show relatively greater 
stress  reactivity  compared  to  good  sleepers.  Whether  there  was  a  difference  in  stress 
reactivity  between  the  NREM  and  Insomnia  groups  had  remained  a  research  question.  
Stress  reactivity  change  scores  (Table  2.5,  p96)  for  HR  and  CVT  were  obtained  by 
calculating the difference in mean HR and CVT between the final minute of the baseline 
phase (B5) and the first minute of the stressor phase (S1). 
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Area under the curve with respect to increase (AUCI) was also calculated as a measure of 
change (from B5 to S5) using formulas to calculate the area under the curve as illustrated in 
the diagram below. AUCI  was calculated to use the baseline (B5) as a reference and ignores 
the distance from zero.  This makes it a sensitive measure of change over time (Fekedulegn, 
2007).  Figure 2.10 (below) illustrates the areas calculated by AUCI for the HR data.  AUCI 
for the CVT data was calculated in a similar manner. 
 
Figure 2.10: Area Under the Curve (B5-S5; HR Data) for GS (upper right), Insomnia 
(middle right) and NREM (lower right) Groups 
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Stress Reactivity (HR) 
Visual inspection of the HR data (Figure 2.8, p89) suggest that the insomnia group shows a 
lesser  stress  reactivity  than  the  NREM  and  GS  groups  which  appear  to  have  a  stress 
reactivity of a relatively similar magnitude to each other. Independent t-tests were carried 
out to investigate differences in stress reactivity between groups. 
 
Table 2.5: Stress Reactivity Change Scores (S1 – B5) 
    HR  CVT 
Group  n  M  SD  M  SD 
GS  15  8.02  5.39  -2.48  4.36 
Insomnia  12  5.28  8.03  -0.62  2.93 
NREM  11  8.07  6.60  -2.44  3.63 
 
Stress reactivity change scores (Table 2.5) of the NREM group did not differ significantly 
from  stress  reactivity  of  the  GS  group   [t  (24)  =  022,  p  =  0.98;  Cohen‟s  d  =  0.01, 
representing  a  very  small  effect  size]  or  the  Insomnia  group  [t  (21)  =  0.91,  p  =  0.38; 
Cohen‟s  d  =  0.38,  representing  a  small-medium  effect  size].  Stress  reactivity  of  the 
Insomnia group did not differ significantly from good sleepers [t (25) = 1.06, p = 0.30; 
Cohen‟s  d  =  -0.40,  representing  a  small-medium  effect  size).    Since  no  significant 
differences were found, the planned one-way between groups ANOVA was not carried out.  
 
AUCI was then analysed in the same manner as the change score data described above. 
Stress reactivity (according to AUCI) of the NREM group (M = 29.23, SD = 17.41) did not 
differ significantly from the GS group [(M = 29.92, SD = 17.89); t (24) = -0.10, p = 0.92; 
Cohen‟s d = -0.04, representing a very small effect size], or the Insomnia group [(M = 14.97, 
SD = 25.21); t (21) = 1.56, p = 0.13; Cohen‟s d = 0.66, representing a medium to large 
effect size]. Stress reactivity of the Insomnia group did not differ significantly from good 96 
 
sleepers [t (25) = -1.80, p = 0.08; Cohen‟s d = -0.68, representing a medium to large effect 
size]. Since no significant differences were found, no further analyses were performed on 
these data. 
 
Stress Reactivity (CVT) 
Visual inspection of the CVT data (Figure 2.9, p90) also showed that the Insomnia group 
had a smaller in magnitude stress reactivity than both the NREM and GS groups, which 
again  appeared  similar  in  magnitude to  each  other.  This  observation  was  confirmed  by 
calculating stress reactivity change scores (Table 2.5).  Mann-Whitney U tests were carried 
out  to  investigate  differences  in  stress  reactivity  (according  to  change  scores)  between 
groups. Stress reactivity in the NREM group (Mdn = -2.44) did not differ significantly from 
the GS group (Mdn = -1.53; U = 79.00, z = -0.18, p = 0.88; Cohen‟s d = -0.07, representing 
a very small effect size), or the Insomnia group (Mdn = -0.41; U = 49.00, z = -1.05, p = 0.32; 
Cohen‟s  d  =  -0.45,  representing  a  small-medium  effect  size).  Stress  reactivity  in  the 
Insomnia group did not differ significantly from good sleepers (U = 7050, z = -0.95, p = 
0.35; Cohen‟s  d =  -0.37, representing a small-medium effect size).  Since no significant 
differences were found, the planned Kruskal-Wallis Test was not carried out on the stress 
reactivity CVT data.  
 
AUCI was then analysed in the same manner as the change score data described above. 
Stress reactivity (according to AUCI) in the NREM group (Mdn = -5.14) did not differ 
significantly from the GS group [(Mdn = -6.51); U = 80.00, z = -0.13, p = 0.92; Cohen‟s d = 
0.05, representing a very small effect size] or from the Insomnia group (Mdn = 0.98; U = 
46.00, z = -1.23, p = 0.24; Cohen‟s d = 0.53, representing a medium effect size). Stress 
reactivity in the Insomnia group did not differ significantly from the GS group (U = 64.00, z 97 
 
=  -1.27,  p  =  0.22;  Cohen‟s  d  =  -0.50,  representing  a  medium  effect  size).  Since  no 
significant differences were found, no further analyses were performed. 
 
The  effect  sizes  calculated  for  group  interactions  of  stress  reactivity  are  presented  in 
Appendix 2.23. As predicted, larger effect sizes were found for group interactions following 
AUC analysis than with the simple change score data.   
 
Recovery 
It was hypothesised that both the NREM and Insomnia groups would show a relatively 
slower return to baseline levels of autonomic arousal compared to good sleepers. Whether 
NREM and Insomnia groups differed in terms of how quickly they returned to their baseline 
autonomic arousal level had remained a research question.  
 
Recovery (HR) 
For each participant, the data were examined to ascertain the first time period in which their 
HR returned to their baseline value or below (Table 2.6). Since HR data were fairly stable 
throughout the baseline phase, the grand mean of B1 to B5 was calculated as the baseline 
value.  The mean HR for each one-minute period was then examined and the first time 
period, subsequent to the initial rise in HR at the beginning of the stressor phase,  with a 
mean HR equal to or less than baseline value was noted. Cumulative percentages were also 
calculated.  Three participants in the Insomnia group and one in the GS group reached their 
baseline HR whilst still in the stressor phase, and at least one participant in each group had 
not returned to baseline by the end of the recovery phase.  On inspection of the cumulative 
percentages, it could be seen that 75% of the Insomnia group had returned to baseline HR 98 
 
during the 1
st minute of the recovery phase and 91.7% during the 2
nd minute.  This appeared 
to represent a generally faster return to baseline HR compared to the NREM and GS groups 
 
 
 
Table 2.6: Recovery Phase: Time Period in which Participants Returned to Baseline HR 
 
  GS  Insomnia  NREM 
Time Period 1
st 
Reached Baseline 
HR 
No. 
Participants  Cumulative %  No. 
Participants  Cumulative %  No. 
Participants  Cumulative
 % 
Reached baseline 
HR during S  1  6.7  3  25  -  - 
R1  6  46.7  6  75  5  50 
R2  2  60.0  2  91.7  2  70 
R3  2  73.3  -  -  1  80 
R 4  -  -  -  -  1  90 
R 5  1  80  -  -  -  - 
Did not reach 
baseline during R  3  100  1  100  1  100 
Total  15    12    10   
 
Note: Due to equipment failure, recovery phase (R) data were not available for one participant in the 
NREM group. 
 
 
Recovery (CVT) 
A similar approach was taken to investigate the time period in which CVT first returned to 
baseline (Table 2.7).  Since CVT data showed a steady decline across the baseline phase for 
the NREM and GS groups, mean CVT for R1 only was used as the baseline value. In all 
groups, at least four participants reached their baseline CVT whilst still in the stressor phase 
and at least one participant had not returned to baseline by the end of the recovery phase.  
Again  the  Insomnia  group  appeared  to  represent  a  generally  faster  return  to  baseline, 
however this is not surprising since CVT had remained fairly stable across all three phases 
in this group. 
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Table 2.7: Recovery Phase: Time Period in which Participants Returned to  
Baseline CVT 
  
Note: Due to equipment failure, recovery phase (R) data were not available for one participant in the 
NREM group. 
 
 
Subjective Stress 
It was hypothesised that the Insomnia group would report relatively higher levels of stress 
than both the GS and NREM groups, and that the NREM group would report the lowest 
level of stress. On visual inspection of the data (Table 2.8), it could be seen that although 
the NREM group did report the lowest level of stress the magnitude of this difference was 
very small and in fact, on average, participants in all three groups reported a similar level of 
stress throughout the experimental procedure.  All three groups reported higher stress levels 
over the stressor phase than the baseline and recovery phases. Multiple Mann-Whitney U 
tests were performed for each set of subjective stress data.  No significant differences were 
found between any two groups at any time point (p ≥ 0.11), confirming the visual inspection 
of the data. The results of these analyses are presented in Appendix 2.22.   
 
  GS  Insomnia  NREM 
Time Period 1
st 
Reached Baseline 
CVT 
No. 
Participants 
Cumulative 
% 
No. 
Participants 
Cumulative 
% 
No. 
Participants 
Cumulative
 % 
Reached baseline 
CVT during S  5  33.3  8  66.7  4  40 
R1  5  66.7  2  83.3  1  50 
R2  -  -  -  -  1  60 
R3  -  -  1  91.7  2  80 
R4  -  -  -  -  -  - 
R5  1  73.3  -  -  -  - 
Did not reach baseline 
during R  4  100  1  100  2  100 
Total  15    12    10   100 
 
Table 2.8: Mean Subjective Stress Scale Scores Across Experimental Procedure 
  Initial 
Stress 
After Baseline 
Phase 
After Stressor 
Phase 
After Recovery 
Phase 
Overall 
Stress 
  M  SD  M  SD  M  SD  M  SD  M  SD 
GS  2.80  2.88  2.07  2.28  6.07  1.94  2.53  1.68  4.33  1.99 
Insomnia  2.18  2.27  1.67  1.56  5.83  2.08  2.73  1.68  4.50  1.51 
NREM  1.46  1.21  1.46  1.21  5.09  2.17  1.91  0.83  4.18  1.99 
   
Effect Sizes and Statistical Power 
The results of this study were generally not found to be statistically significant, however 
some  substantial  effect  sizes  were  observed  (Appendix  2.23).    The  small  sample  size 
indicated  that  the  study  was  likely  to  be  underpowered.    To  investigate  this,  post  hoc 
calculations were carried out in order to compute achieved power for the baseline and stress 
reactivity  data  (Appendix  2.23).  The  results  confirmed  that  the  study  was  indeed 
underpowered (achieved power ranging from 0.05 – 0.39), with the exception of the one 
interaction producing a statistically significant result (NREM-Insomnia for baseline CVT; 
power of 0.75). 
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Discussion 
 
NREM parasomnias are a relatively un-studied group of sleep disorders; less being known 
about this population compared to other sleep disorders, such as insomnia, and there being 
few treatments offered even to those whose condition causes significant distress or risk to 
themselves or others. This study was exploratory in nature, the purpose of which was to gain 
greater insight  into  how people  with  NREM  parasomnia  respond to  „threat‟  and  to life 
situations.  
 
In particular, the aim was to investigate how their responses to a psychological stressor 
compared to individuals with insomnia and good sleepers by measuring autonomic arousal, 
as well as subjective appraisals of stress. Baseline levels of autonomic arousal were also 
intended to provide insight into daytime arousal levels at the trait level.   
 
Baseline Autonomic Arousal 
As expected, both the NREM parasomnia and Insomnia groups exhibited a relatively higher 
resting  baseline  HR  compared  to  the  good  sleeper  group,  indicating  a  higher  level  of 
underlying sympathetic arousal. The two sleep disorder groups did not differ from each 
other.  HR (all groups) appeared to remain stable throughout the 5-minute baseline period.  
This contrasted with the baseline CVT data, where the NREM group had the highest values 
and the insomnia group the lowest, suggesting that the NREM group may be in a more 
restful state.  Both the NREM and the GS groups then appeared to become less relaxed 
throughout the baseline period, perhaps due to anticipation of the task ahead. The insomnia 
group  had  considerably  lower  CVT  which  remained  fairly  stable  throughout  all  phases 
suggesting a constant level of elevated arousal in relative terms.  This finding is in line with 102 
 
previous research which has found individuals with insomnia to have greater autonomic 
arousal compared to normal sleepers, both during the day and in the pre-sleep period (e.g. 
Bonnett & Arand, 1996, 1998; Stepanski et al., 1989, 1994; Haynes et al., 1974, 1981; 
Monroe, 1967; Freedman & Sattler, 1982; Riemann et al., 2010). 
 
HR can increase due to a reduction in parasympathetic activity (CVT) or an increase in 
sympathetic activity.  Both can happen simultaneously and this is what typically happens in 
response to stress. In this study, the insomnia group appeared to have CVT that was already 
so low that it could not have gone much lower in reaction to the stressor; the so-called floor 
effect.  HR  did,  however,  increase  during  the  stressor  phase  perhaps  due  to  increased 
sympathetic drive. These data suggest that the insomnia group may go through day-to-day 
life with a slightly raised level of autonomic arousal as a trait-like feature, in comparison to 
those without difficulty sleeping.  This pattern, however, was not observed in the NREM 
group.  The only statistically significant finding was that baseline CVT in the insomnia 
group  was  lower  than  in  the  NREM  group  (representing  a  very  large  effect  size)  The 
difference between Insomnia and GS baseline CVT represented a medium-large effect size, 
although a statistically significant difference was not observed. Baseline autonomic arousal 
differed  very  little  between  the  NREM  and  GS  groups.  However,  as  described  above, 
medium-large and very large effect sizes were found between the insomnia group and GS 
and NREM groups respectively. It was the insomnia group which seemed to differ from 
good sleepers with regards to baseline autonomic arousal and not the NREM group. 
 
Stress Reactivity 
Although failing to achieve statistical significance, HR appeared to increase to a greater 
degree in response to the stressor in the NREM and GS groups.  A likely explanation is that 103 
 
changes in both sympathetic and parasympathetic activity combine to make the increase 
larger relative to the insomnia group.  No significant differences were found between groups 
for  stress  reactivity.  However  as  predicted,  larger  effect  sizes  were  found  for  group 
interactions following AUC analysis than with the simple change score data.  The results 
indicated that the NREM group differed little from the GS group in terms of stress reactivity.  
Nevertheless, medium-large effect sizes were found between the Insomnia and NREM, and 
Insomnia and GS groups for AUC HR; and medium effect sizes were found between the 
Insomnia and NREM, and Insomnia and GS groups for AUC CVT. As with the baseline 
data, it was the insomnia group which differed from the GS group, but in the opposite 
direction to that predicted. That is, the insomnia group appeared to react less to stress. This 
is inconsistent with previous research findings which have found reports of increased stress 
and  stress  reactivity  in  individuals  with  insomnia  compared  to  good  sleepers  (e.g. 
Vogontzas et al., 1998; Morin et al., 2003). However, this finding may to be due to the 
uniformly low CVT level measured in the Insomnia group throughout the procedure, which 
may have prevented this group from „reacting‟ to the stressor with further lowered CVT. 
 
Recovery 
Analysis of recovery phase data were difficult to meaningfully analyse due to the method of 
analysis adopted, i.e. average HR and CVT were calculated for consecutive one-minute 
periods throughout all phases of the procedure.  Complicating this method further for the 
recovery phase data was the fact that participants took varying lengths of time to complete 
the stressor phase.  To avoid the problem of missing data, it was decided that only data from 
the first 5 minutes of the stressor phase were included in analysis since these data were 
complete for all but one of the included participants. However, this method of analysis 
meant that, for the majority of participants, data between S5 and R1 was not continuous and 104 
 
contained a „missing‟ time period of varying length. This attribute of the data contributed 
further to the challenge of analysing the recovery data.  The analysis that was carried out 
indicated that participants in the insomnia group generally returned to their baseline level of 
autonomic arousal (HR and CVT) the most quickly, followed by the NREM group and then 
the good sleepers.  This is not in line with the hypotheses, however, on reflection it is 
perhaps not surprising since the HR data of the insomnia group increased to a lesser extent 
than the other two groups and the CVT data appeared not to increase at all in response to the 
stressor.  
 
If the study were to be repeated, it would be interesting to analyse  recovery data using 
„running medians‟ which could have the effect of smoothing the data. This would be a 
useful technique to use with the time series data, which could help reduce the effects of 
fluctuations in the data so that trends could be more easily seen.  Using this technique, a 
„race‟ could be created in order to investigate how quickly individuals returned to their 
baseline level and in which order.  
 
Subjective Stress 
All three groups reported similar levels of subjective stress, confirming the pilot data that 
the experiment was stressful, with greater perceived stress being reported during the stressor 
phase than in either the baseline or the recovery phases. Although the groups did not differ, 
this data did demonstrate that, at a subjective level, all groups perceived a similar level of 
stress even where variations in the objective measures were observed.  Morin et al. (2003) 
found that individuals with insomnia tended to appraise their lives as more stressful than 
good sleepers, even though both groups reported similar levels of stressors.  The findings of 
this study were not in line with Morin et al.‟s findings since the Insomnia group did not 105 
 
subjectively report feeling any more stressed than the other groups. However, this could be 
partly due to their increased arousal being associated with a lower overall CVT, rather than 
in reaction to the stressor. The subjective stress data results were not in line with previous 
research  findings  that  individuals  with  NREM  parasomnias  may  have  a  capacity  to 
dissociate  or  inhibit  emotion  during  wakefulness  (Crisp,  1996;  Crisp  et  al.,  1990; 
Klackenberg, 1982).  Similarly they were not in line with suggestions that individuals with 
NREM parasomnias may respond to stressors with high physiological arousal suggestive of 
anxiety, whilst not being aware of this anxiety at a conscious level, as in Derakshan & 
Eysenck‟s (1999) description of „repressors‟. It is also possible that the stressor was not 
„stressful‟ enough, or was not of the type, to observe these effects. It is perhaps of note that 
the NREM group had a consistently higher mean HR compared to the good sleeper group 
throughout all phases, which was not reflected in the subjective data. 
 
Participant and Methodological Variables 
Effects  may  also  have  been  partly  obscured  by  participant  or  methodological  variables. 
Although the age of participants varied between groups, this was in line with what would be 
expected, given the prevalence rates in the general population. This adds strength to the 
study in terms of validity.  Covariates were investigated and found not to affect the results. 
A  possible  confounding  variable  which  was  not  investigated  or  controlled  for  is 
cardiovascular fitness. It would have been useful to have asked a cardiovascular fitness 
question as part of the screening interview. Another factor is the influence of ability. Some 
individuals were likely to have found the procedure more stressful than others in all three 
groups.  The data indicated that both participants‟ perception of how well they performed 
during the stressor task and the percentage of questions answered correctly were normally 
distributed  across  the  study  population.  Neither  of  these  variables  were  found  to 106 
 
significantly differ across groups. It was therefore concluded that the influence of ability 
was not likely to have been a confounding variable.  However, it would perhaps have been 
useful  to  have  also  gathered  information  about  participants‟  level  of  education.    This 
information, as well as being informative regarding the influence of ability, could have also 
been  used  as  an  indicator  relevant  to  socio-economic  status.    This  demographic  was 
investigated by gathering postcode data and using the SIMD database to calculate a quintile 
score based on relative deprivation of data zones.  The limitation of this method is that 
deprivation  is  measured  according  to  geographical  area  and  may  not  provide  a  valid 
measure of socio-economic status at an individual level. 
 
Autonomic arousal is thought to vary over time of day. In general, arousal increases during 
the morning, stabilises during the afternoon and then decreases again during the evening 
(Revelle & Loftus, 1992).  It was not possible, for practical reasons, for all participants to 
take part during a specific daytime period.  Although time of day of participation was not 
found to significantly differ across groups, so this may have had limited influence on the 
experimental data.  
 
Two participants in the insomnia group reported medication use (Citalopram, 20mg) on 
arrival  at  the  UGSC,  which  they  had  not  disclosed  during  the  screening  process. 
Antidepressants,  and  the  problems  they  are  prescribed  for,  are  potential  confounding 
variables in the study. One of these individuals had only commenced on the medication a 
few days previously.  Since both participants had travelled to the UGSC and wished to take 
part,  they  were  run  through  the  procedure.    The  data  of  these  two  participants  were 
subsequently examined.  Their physiological data did not contain extreme values or deviate 
from the typical pattern of responding.  Advice was also sought from a psychiatrist about 107 
 
the  potential  effect  this  medication  may  have  on  these  participants‟  physiological  data. 
Selective serotonin reuptake inhibitors (SSRIs) like citalopram seem to be less of an issue 
than other medications regarding potential confounding effects on the physiological data 
(Rottenberg, 2007).  Due to the exploratory nature of this study, and because the doses of 
citalopram  involved  were  low  (and  in  one  of  the  participants  very  short  term),  it  was 
decided that these two participants could be included in the analysis.  
 
Only  one  participant  included  in  analysis  reported  significant  mental  health  difficulties.  
This  individual  was  in the  NREM  group  and  met  criteria  for  major  depressive  episode 
current and recurrent on the M.I.N.I.  This participant reported that her symptoms were 
currently  stable,  she  was  receiving  cognitive  behavioural  treatment  at  the  time  of 
participation and was not taking any medication. On analysis of the physiological data, no 
extreme values were observed and the data followed the typical observed pattern. 
 
 
Strengths and Limitations 
A  strength  of  this  study  is  that  a  thorough  screening  procedure  was  employed  and 
participants were recruited according to specific diagnostic criteria, inclusion and exclusion 
criteria. This was supported by analysis of the questionnaire data which confirmed group 
allocation. Also a strength is that all experimental procedures were piloted and standardised, 
were  carried  out  according  to  UGSC  standard  operational  procedure  and  in  the  same 
bedroom  and  with  the  same  equipment.    Participants  were  provided  with  identical 
instructions and explanation which was given in writing, via the participant information 
sheet, verbally by the researcher with the aid of a script and on-screen during the procedure.  
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Limitations  to  this  study,  which  may  affect  the  generalisation  of  findings,  include  the 
participant and methodological variables discussed above.  The results of this study were 
generally not found to be statistically significant, however some substantial effect sizes were 
observed.  The small sample size indicated that the study was likely to be underpowered and 
post hoc calculations confirmed this to be the case.    A total sample size of 69 participants 
was calculated to be required to detect a large effect size. Thirty-eight participants were 
included  in  this  study,  which  is  only  55%  of  the  estimated  required  sample  size.  
Recruitment had been more difficult than expected.  Although contact was made with a 
large  number  of  potential  participants,  exclusions  were  made  due  the  strict 
inclusion/exclusion criteria.  Additionally, there were potential participants who, although 
interested, were not able or did not wish to attend the Southern General Hospital at a later 
date to participate.  The distance participants would have to travel was a factor as was time 
of day.  Due to researcher availability, it was only possible to run participants on certain 
days, and the sleep laboratory was only available at specific times.  Unfortunately these 
times  did  not  suit  some potential  participants  who  were  otherwise  willing  to  take  part.  
These restrictions undoubtedly affected the obtained sample size. 
 
This study was intended to be exploratory in nature and a repetition of this study with a 
larger number of participants would be interesting.  However, prior to that, the data from 
part B, the previously described repetition aspect of the study, should be analysed.  It would 
be informative to observe whether similar effects are observed on analysis of the data from 
part B.  If so, this would indicate the stability or otherwise of the findings thus far.  
 
All three groups did generally differ from each other in a consistent way throughout the 
procedure.  For example, the NREM group had the highest level of CVT, and the Insomnia 109 
 
group  the  lowest  throughout  all  phases.    There  was  some  crossover  in  the  HR  data 
(particularly with the Insomnia group), although it was observed that the NREM group had 
consistently higher HR than the GS group.  The data from each group also appear to follow 
similar patterns of response, with the exception of the consistently low CVT in the insomnia 
group.  These observations suggest that further investigation may be worthwhile.   
 
Another limitation is that there was a problem with the timing pulse in a proportion of 
participants‟ data occurred for an unknown reason.  This meant that, for these participants, 
analyses had to rely on the hand noted times for phase beginnings and ends.  Whilst these 
times  were  routinely  recorded  as  accurately  as  possible,  there  may  have  been  small 
fluctuations  in  the  accuracy.  It  is  estimated  that  for  these  participants,  the  possible 
inaccuracy in the time of phase beginnings and endings is not likely to be more than a few 
seconds.  Also of note is a known design weakness, which is that participants took different 
lengths of time to complete the stressor phase.  This issue was considered during the design 
of the study but it was not possible to appropriately programme the software to limit the 
stressor phase to a specific length of time.  
 
Implications 
The  findings  of  this  type  of  study  have  potentially  important  implications  for  the 
development  of  treatment  programmes  for  NREM  parasomnias.  However,  further  work 
needs to be done before any conclusions can be drawn.  The study was intended as an 
exploratory study and the preliminary findings indicate that further exploration is warranted. 
The  first  step  would  be  to  analyse  the  replication  data  to  investigate  if  the  results  are 
replicated.  As the results stands, it appears that individuals with NREM parasomnias react 110 
 
to stressors in a similar manner to good sleepers but may have a slightly higher resting 
sympathetic activity (similar to those with insomnia).   
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Abstract 
 
The  following  reflective  account  is  based  upon  my  experiences  of  working  within  a 
community mental health team.  I draw on Gibbs‟ (1988) model of reflection and Rolfe et 
al.‟s (2001) framework for reflective practice to consider my experience of working with an 
individual with a diagnosis of bipolar disorder.  I consider the thoughts and emotions I 
experienced at various points whilst working directly with the patient as well as indirectly 
with  other  members  of  a  multidisciplinary  team  in  order  to  gain  a  more  detailed 
understanding of the client and her difficulties, and to consider effective approaches for 
assessment and intervention. 
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Abstract 
 
The following reflective account is based upon my experience of working within a specialist 
trauma service providing mental health care for asylum seekers and refugees with complex 
difficulties.  I draw on structured reflective models (Boud, Keogh and Walker, 1985; Gibbs, 
1988) to reflect on my experience of helping to run a group intervention for male survivors 
of  torture.    This  experience  has  contributed  to  my  professional  development  as  I  have 
learned skills and become more aware of issues that will help me to plan, manage and run 
groups in the future.  I also consider equalities legislation and the Equality Scheme 2010-
2013 and reflect on how this relates to asylum seekers and refugees, and their experience of 
accessing services. 
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Appendix 1.2 
Excluded Articles 
Article   Author  Reason for Exclusion 
1  Cortoos et al. (2010b)  Conference publication – full text not obtained. 
2  Kazarian et al. (1978)  Not investigating effect of biofeedback on 
insomnia. 
3  Heaton & Rayens (2010)  Participants did not have sleep difficulties. 
4  Budzynski (1973)  Outcome measures and results data not reported. 
5  Stoyva et al. (1974)  Abstract only. 
6  Besner, H.F. (1978)  Abstract only. 
7  Good (1975)  Study did not use group design. 
8  Montgomery & Besner (1975)  Not able to obtain article. 
9  Hauri & Good (1975)  Conference publication – full text not obtained. 
10  Sittenfield (1972)  Abstract only. 
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Appendix 2.2: Diagnostic Criteria for Insomnia and NREM Parasomnia Groups 
 
Participants in the insomnia group met the following ICSD-2 criteria: 
General Criteria for Insomnia 
A.  A complaint of difficulty initiating sleep, difficulty maintaining sleep, or waking up too 
early or sleep that is chronically non-restorative or poor in quality. 
B.  The above sleep difficulty occurs despite adequate opportunity and circumstances for 
sleep. 
C.  At least one of the following forms of daytime impairment related to the night time 
sleep difficulty is reported by the patient: 
i.  Fatigue or malaise 
ii.  Attention, concentration, or, memory impairment 
iii.  Social or vocational dysfunction 
iv.  Mood disturbance or irritability 
v.  Daytime sleepiness 
vi.  Motivation, energy, or initiative reduction 
vii. Proneness for errors or accidents at work or while driving 
viii.  Tension, headaches, or gastrointestinal symptoms in response to sleep loss 
ix.  Concerns or worries about sleep 
 
Participants in the NREM parasomnia group met the following ICSD-2 diagnostic criteria 
for Disorders of Arousal (from NREM Sleep). 
Sleepwalking 
A.  Ambulation occurs during sleep. 
B.  Persistence of sleep, an altered state of consciousness, or impaired judgment during 
ambulation is demonstrated by at least one of the following: 
i.  Difficulty in arousing the person 
ii.  Mental confusion when awakened from an episode 
iii.  Amnesia (complete or partial) from an episode 
iv.  Routine behaviours that occur at inappropriate times 
v.  Inappropriate or nonsensical behaviours 
vi.  Dangerous or potentially dangerous behaviours 
C.  The  disturbance  is  not  better  explained  by  another  sleep  disorder,  medical  or 
neurological disorder, mental disorder, medication use, or substance use disorder. 
 
Sleep Terrors 
A.  A sudden episode of terror occurs during sleep, usually initiated by a cry or loud scream 
that is accompanied by autonomic nervous system and behavioural manifestations of 
intense fear. 
B.  At least one of the following associated features is present: 
i.  Difficulty in arousing the person 
ii.  Mental confusion when awakened from an episode 
iii.  Amnesia (complete or partial) for the episode 
iv.  Dangerous or potentially dangerous behaviours 
C.  The  disturbance  is  not  better  explained  by  another  sleep  disorder,  medical  or 
neurological disorder, mental disorder, medication use, or substance use disorder. 127 
 
Appendix 2.3: Sleep Research Recruitment Poster 
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Appendix 2.4 
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Appendix 2.5: PSQI (excluding bed partner questions) 
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Appendix: 2.6 
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Appendix: 2.7 
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Appendix 2.8: Visual-analogue Stress Scale 
 
How did you feel during the last few minutes? 
 
0         1        2        3        4        5        6        7        8        9        10 
Very                     Very 
Calm                     Stressed 
 
Please respond by saying the appropriate number out loud… 
… then press any button to continue. 
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Appendix 2.9: Participant Screening Interview: Adapted from GUSC standard 
screening interview 
 
Participant ref no:   Today’s date:  
 
Source (to be answered by all participants) 
 
How did you find out about the 
University of Glasgow Sleep Centre? 
 
Why have you contacted us?   
Method of initial contact (e.g. mobile, 
email) 
 
 
 
Personal (to be answered by all participants) 
   
Full Name: 
 
Date of Birth:  Age: 
Telephone (home, mobile): 
 
 
Address: 
 
 
 
 
 
Postcode: 
Email: 
 
When is a good time to call? 
What GP practice do you attend, and who 
is the GP you normally see? 
 
 
 
 
Do you give your consent for us to contact your 
GP if necessary regarding your health? 
 
 
Do you have difficulty sleeping at the moment? (Y/N) 
 
Are you generally satisfied with the amount of sleep you get (Y/N) 
Do you work shifts, night shifts? 
 
Are you aware of any other family members with a sleep disorder? 
If yes please specify: 
E.g. Do either of your parents have sleep difficulties (now or in the past)?  
What about brothers and sisters?  
What about extended family including grandparents?  
 134 
 
Health (to be answered by all participants) 
Do you keep in good health physically? (Y/N) 
 
What physical health problems do you have (if applicable)? 
(Could your sleep difficulties be due to any other physical health problems or medication use?) 
What medicines do you take for your physical health? (if applicable) 
 
 
Roughly, how many units of alcohol do you drink per week?     
(Standard (175ml) glass of wine = 2 unit;  One pint of standard lager = 2.3  units;  Spirit & Mixer   = 
1 unit) 
 
 
 
Do you take recreational drugs? If so, how often? (e.g. once per week/month etc) 
 
Do you keep in good health mentally? (Y/N) 
 
What mental health  problems do you have (if applicable)? 
 
 
What medicines do you take for your mental health? (if applicable) 
 
 
 
Screen for Possible Sleep Disorders Other Than Insomnia.  
(to be answered by all participants) 
 
1. Narcolepsy 
a. Do you sometimes fall asleep in the daytime completely without warning? (YES/NO) 
If Yes…. 
b. Is it literally impossible to resist ‘sleep attacks’ during the day? 
c. Do you have collapses or extreme muscle weakness triggered by extreme emotion? 
d. Do you have visual hallucinations, either just as you fall asleep or when you wake in the morning? 
e. Are you paralysed and unable to move when you wake up from your sleep? 
 
[OFFICE USE ONLY: Possible narcolepsy: 1a¼‘‘TRUE’’ AND (1b OR 1c OR 1d OR 1e¼‘‘TRUE’’)]  
 
2. Sleep breathing disorder 
a. Are you a very heavy snorer? (YES/NO) 
If Yes… 
b. Does your partner say that you sometimes stop breathing? 
c. Do you often wake up gasping for a breath? 
d. Are you often excessively sleepy during the day or fall asleep without wanting to? 
 
[OFFICE USE ONLY: Possible sleep breathing disorder: 2a¼‘‘TRUE’’ AND (2b OR 2c OR 2d¼‘‘TRUE’’)] 135 
 
3. PLMS/ RLS 
a. Do your legs often twitch or jerk or can’t keep still in bed?(YES/NO) 
If Yes… 
b. Is it very difficult to get to sleep because of repeated muscle jerks? 
c. Do you frequently wake from sleep with sudden jerky movements or with a compulsion to move your 
legs? 
d. Do you simply have to get out of bed and pace around to get rid of these feelings? 
 
[OFFICE USE ONLY: Possible PLMS/ RLS: 3a¼‘‘TRUE’’ AND (3b OR 3c OR 3d¼‘‘TRUE’’)] 
 
4. Circadian Rhythm Sleep Disorder 
a. Do you tend to sleep well but just at the ‘‘wrong times’’? (YES/NO) 
If Yes… 
b. Can you sleep well enough, but only if you stay up very late? 
c. Are you in a very sound sleep at normal waking time and could sleep on for hours more? 
d. Can you sleep well enough, but only if you go to bed very early? 
e. Do you wake very early, bright and alert and no longer sleepy? 
 
[OFFICE USE ONLY: Possible CRSD: 4a¼‘‘TRUE’’ AND EITHER (4b AND 4c¼‘‘TRUE’’) OR (4d AND 4e¼‘‘TRUE’’)] 
 
5. Parasomnia 
a. Do you have unusual behaviours, like sleepwalking,  associated with your sleep that trouble you 
or that are dangerous?(YES/NO) 
If Yes… 
b. Do you sleepwalk frequently and run the risk of injuring yourself or others? 
c. Do you have frequent night terrors when you are extremely distressed but not properly awake? 
d. Do you act out your dreams and risk injuring yourself or others? 
e. Do you have terrible recurring nightmares? 
 
[OFFICE USE ONLY:  Possible parasomnia: 5a¼‘‘TRUE’’ AND EITHER (5b OR 5c OR 5d OR 5e¼‘‘TRUE’’ 
 
If YES to b. or c. 
  Do you currently experience these?(YES/NO) 
  How often in the past 6 months? 
 
Insomnia (if applicable) 
Have you always been a poor sleeper? (Y/N) 
 
How long have you had a sleep problem?(yr) 
Do you have difficulty falling asleep? (Y/N)  
How many nights per week do you have difficulty falling asleep? (out of 7)  
How long does it normally take you to fall asleep?(min) 
 
Do you experience sleep disturbance because of waking during the night?(Y/N) 
How many nights per week do you have a difficulty with waking up during the night?(out of 7) 
How long are you normally awake during the night, in total? (min) 
 
What time do you normally go to bed? (time)  
What time do you normally get up?(time) 
How long do you normally sleep?(hr/min) 136 
 
Sleepwalking (if applicable) 
Do you sleep walk or carry out any other activities during sleep.   Please describe any activities that 
occur in addition to walking (e.g. eating, sex, undressing/.dressing)? 
 
 
 
Is it difficult to arouse you from the sleep state during these events? 
 
Have you experienced mental confusion when awakened from an episode? 
Do you have any memory of such events upon awakening?  
How often do these events occur in general (e.g. once per week/once per month)? 
 
How many in last 6 months? 
How long ago did you last experience this event?   
Approximately how old were you when you first experienced an event like this?  
Do you know whether this occurs at the beginning, middle or end of your sleep?  
 
Night Terrors (if applicable) 
Do you experience sudden episodes of intense terror during sleep? 
 
Do you engage in any dangerous or potentially dangerous behaviours at these times? (if so, please 
describe) 
 
Do you have any memory of such events upon awakening?  
Is it difficult to arouse you from the sleep state during these events? 
Have you experienced mental confusion when awakened from an episode?  
How often do these events occur in general (e.g. once per week/once per month)? 
How long ago did you last experience this event?  
Approximately how old were you when you first experienced an event like this?  
Do you know whether this occurs at the beginning, middle or end of your sleep?  
 
All Sleep Disorders (to be answered by those with a sleep disorder) 
Does your sleep disturbance affect how you feel and function during the day (e.g. fatigue, sleepiness, 
concentration, memory, mood, motivation, irritable, work/social functioning etc.).  If yes, specify most 
salient.  
Other Studies (to be answered by all participants) 
We are also running a lab based study.  Would you be interested in being contacted about this study?  
If you are not suitable for any of the studies ongoing at the moment are you happy for your details to be kept on a 
database so that you may be contacted in the future should a suitable study start? 137 
 
Appendix 2.10 
 
 
           
   
University of Glasgow Sleep Centre 
Sackler Institute of Psychobiological Research 
2
nd Floor 
Neurosurgery Building 
Southern General Hospital 
Glasgow G51 4TF 
Tel: 0141 232 7699 
 
 
STRESS REACTIVITY IN INDIVIDUALS WITH NON-REM PARASOMNIAS, 
INSOMNIA AND GOOD SLEEP 
 
 
 
PARTICIPANT INFORMATION SHEET  
 
My name is Sarah Young.  I am a trainee clinical psychologist from the University of 
Glasgow working with Professor Colin A Espie, Director of the University of Glasgow 
Sleep  Centre.    I  would  like  to  invite  you  to  take  part  in  a  study  looking  at  how 
individuals with Non-REM parasomnias (e.g. sleepwalking, night terrors), insomnia and 
good sleep respond while doing a mental task.  I am interested to see how the mind and 
body responds while doing both easy and difficult tasks by measuring heart rate and 
asking  individuals  about  their  experience.  The  information  gathered  is  for  research 
purposes only and is a requirement of my training.  You will not be identifiable in the 
results.   
 
Before you decide whether or not to take part, it is important for you to understand why 
the research is being carried out and what it will involve.  Please take your time to read 
the following information carefully.  If there is anything that is unclear or if you would 
like more information, please let me know.  Take your time to decide whether or not you 
wish to take part.   
 
What is the title of this project?  
Stress Reactivity in Individuals with Non-REM Parasomnias, Insomnia and Good Sleep. 
 
Why is the study important?  
The current  research investigating psychological  processes in  people with non-REM 
parasomnias (e.g. sleep walking, night terrors) is limited.  Comparing people with non-
REM parasomnias to those with insomnia as well as good sleepers will help build on 
what we do know and may be relevant to developing appropriate treatments in this area.    138 
 
 
What are the aims of this study?  
The aim of this study is to investigate how people with non-REM parasomnias respond 
to  doing  a  mental  task  by  measuring  their  heart  rate  and  asking  them  to  rate  how 
stressful they found the experience.  I will compare the responses of individuals with 
non-REM parasomnias to those with insomnia and good sleep. 
 
Who can take part in this study?  
Adults  who  experience  non-REM  parasomnias  (e.g.  sleep  walking,  night  terrors)  or 
insomnia as well as those who consider themselves to be good sleepers. 
 
Individuals will not be able to take part if they experience other sleep disorders e.g. 
sleep apnoea or restless leg syndrome, neurological disorders e.g. narcolepsy or epilepsy, 
cardiac  problems,  pregnancy  or  medications  affecting  heart  rate.    Individuals  with 
mental health problems will be excluded if their symptoms are severe and/or untreated.  
Individuals with stable and treated symptoms may be included.  Those with significant 
drug or alcohol use will also be excluded. 
 
Do I have to take part?  
You do not have to take part in this study.  Participation is entirely voluntary.  If you do 
decide to take part you will be given this information sheet to keep and be asked to sign 
a consent form.  If you decide to take part you are still free to come out of the study at 
any time without giving a reason.  
 
What does participation in this study involve?  
If  you decide to take part,  you will be asked to meet with me at the University of 
Glasgow  Sleep  Centre,  based  in  the  Southern  General  Hospital  at  a  time  that  is 
convenient to you. You will be given the chance to ask questions and will sign the 
consent form.  You may then be asked questions relating to your psychological well-
being before participating in the main part of the study.  You will attend the Sleep 
Centre for approximately 1½ hours. 
 
The main part of the study will take place in one of the bedrooms in the Sleep Centre.  
You will be asked to lie in a comfortable position on top of the bed and your heart rate 
will be monitored continuously throughout several phases which will involve both rest 
periods and phases in which you will carry out a mental task by following instructions 
on a computer screen.  Some parts of the task may be easy and some may be difficult.   
 
Heart rate will be measured using a standard procedure which is frequently carried out at 
the  Sleep  Centre.    This  will  involve  four  small  adhesive-backed  electrodes  being 
attached  to  your  chest  and  waist  using  a  gel.    You  will  also  be  asked  to  rate  how 
stressful, if at all, you found the experience of the mental task.  
 
Are there any risks involved? 
The  risks  relating  to  taking  part  in  this  study  are  minimal.  The  simple  monitoring 
procedure involved is frequently carried out at the Sleep Centre by trained staff. 139 
 
 
There is a possibility that some individuals may experience a minor skin irritation due to 
the  attaching  of  the  electrodes.    There  is  also  a  possibility  that  a  pre-existing,  but 
previously unidentified, mental health problem or cardiac condition may be discovered.  
If this were to occur, it would be discussed with you and you would be provided with 
advice, information and referrals as necessary.  We would also inform your GP. 
 
What will happen to all of the information?  
All of the information collected about you during the research study will be kept strictly 
confidential.  Personal details (such as your name and address) will not be stored on 
computer, so that you cannot be recognised from it.  
 
Written feedback will be provided to those who request it following completion of the 
study. 
 
Who is supervising this study?  
My  research  supervisor,  Professor  Colin  Espie,  who  works  for  the  University  of 
Glasgow, will supervise me. 
 
Who is paying for this study?  
This study is being funded through the University of Glasgow and has been reviewed by 
a Research Ethics Committee.  The committee has approved the research as appropriate. 
 
What if something goes wrong? 
If you wish to complain, or have any concerns about any aspect of the way you have 
been  approached  or  treated  during  the  course  of  this  study,  you  can  contact  my 
supervisor, Professor Colin Espie at the University of Glasgow (Tel: 0141 232 7699), 
who will be able to advise you on the appropriate complaints procedure, should you 
wish to use this. 
 
What should I do if I have any questions about this study?  
If you would like further details about the study, you can either contact me by phone or 
email.   
 
What do I do now if I want to take part in this study?  
If you decide that you would like to take part in the study you can either contact me on 
(telephone number) or (email address). 
 
You  are  under  no  obligation  to  take  part;  participation  in  this  study  is  completely 
voluntary.  You do not have to give a reason for not wanting to take part in this study.   
 
I would like to take this opportunity to thank you for your time and consideration  
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Participant Identification Number:  
 
 
 
CONSENT FORM 
 
Title of Project: Stress Reactivity in Individuals with Non-REM Parasomnias, Insomnia and Good Sleep 
Name of Researcher: Sarah Young 
                                                                                                                            Please initial box  
 
1.  I confirm that I have read and understand the information sheet dated March 2011  
(version 3) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.  
 
2.   I understand that my participation is voluntary and that I am free to withdraw at any time  
without giving any reason, without my medical care or legal rights being affected.  
 
3.  I understand that data collected during the study, may be looked at by individuals from the 
  University of Glasgow, from regulatory authorities or from the NHS Trust, where it is relevant 
to my taking part in this research. I give permission for these individuals to have access to my  
records.  
 
4.  I give consent for my GP to be contacted if an undiagnosed medical condition is suspected. 
 
 
5.   I agree to take part in the above study.  
 
_____________________  ________________   __________________________  
Name of Patient     Date       Signature  
 
 
_____________________   ________________   __________________________  
Name of Person     Date       Signature  
taking consent  
 
 
When completed, 1 for patient; 1 (original) for researcher site file. 
 
University of Glasgow Sleep Centre 
Sackler Institute of Psychobiological Research 
Southern General Hospital 
Glasgow G51 4TF 
Tel: 0141 232 7699 
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Appendix 2.12 
Verbal Instructions to Participants 
 
  The video camera in the room is not in use. 
 
  The  microphone  is  switched  on  and  I  will  be  able  to  hear  you  throughout  the 
experiment from the control room.  I will be in the control room while you complete 
the experiment. 
 
  Able to see the screen properly and read the text clearly? – (Adjust if necessary) 
 
  Follow the instructions on the screen to move through the experiment and respond 
using the response buttons. 
 
  It is important that you remain as still as possible throughout the experiment.  Even 
small movements will affect the heart rate recordings.  
 
  The only movement you should make is to push the response buttons with your 
fingers.  
 
  Please find a comfortable position and remain looking at the screen throughout. 
 
  You will begin with a short training phase which will allow you to practice using the 
response buttons. 
 
  The experiment involves two halves with a break in the middle to allow you to move 
around.  During the break you may move around where you are on the bed or you 
may get up to walk around. If you wish to walk around, please wait for assistance 
with the wires before you get up. 
 
  In each half there are 3 phases, and each phase lasts about 5 minutes, one phase in 
each half may last a little longer depending on how long you take to complete it.  
 
  After each phase you will be asked how you are feeling on a scale of 1-10.  Please 
respond by saying the appropriate number out loud.  I will be able to hear you from 
the control room. 
 
  Part  of  the  experiment  will  involve  you  being  asked  a  series  of  mathematical 
questions.  You are likely to find some quite difficult and some easier. I‟m interested 
to see how well you can do.  Your goal is to try to answer as many questions 
correctly as you can, as quickly as you can. 
 
  Do you have any questions? 142 
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Participant Response Button Training Diagram 
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Appendix 2.14 
 
 
Baseline and Recovery Phase Picture Stimuli 
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Appendix 2.15: Examples of Stressor Phase Stimuli 
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Carry out the following calculation: 
 
13 x 7000 
 
 
(1) 91 000 
(2) 73 000 
(3) 210 000 
(4) 137 000 
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Out of time. 
Too slow! 
Appendix 2.16 
 
Stressor Phase Response Messages 
 
 
Correct Response                                           Incorrect Response     
   
 
 
Too Slow Response 
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Appendix 2.17 
 
HR Data 
 
Time Period  Levene‟s Test Result 
B1  F(2, 35) = 1.016, p = 0.372 
B2  F(2, 35) = 1.273, p = 0.292 
B3  F(2, 35) = 1.581, p = 0.220 
B4  F(2, 35) = 1.044, p = 0.362 
B5  F(2, 35) = 0.625, p = 0.541 
S1  F(2, 35) = 0.285, p = 0.754 
S2  F(2, 35) = 0.030, p = 0.970 
S3  F(2, 35) = 0.130, p = 0.879 
S4  F(2, 35) = 0.304, p = 0.739 
S5  F(2, 35) = 0.067, p = 0.935 
R1  F(2, 35) = 0.740, p = 0.484 
R2  F(2, 35) = 0.657, p = 0.524 
R3  F(2, 35) = 0.274, p = 0.762 
R4  F(2, 35) = 0.626, p = 0.540 
R5  F(2, 35) = 0.745, p = 0.482 
 
CVT Data 
 
Time Period  Levene‟s Test Result 
B1  F (2, 36) = 2.239, p = 0.121 
B2  F (2, 36) = 1.975, p = 0.154 
B3  F (2, 36) = 2.165, p = 0.129 
B4  F (2, 36) = 1.493, p = 0.238 
B5  F (2, 36) = 1.288, p = 0.288 
S1  F (2, 36) = 1.639, p = 0.208 
S2  F (2, 36) = 1.952, p = 0.157   
S3  F (2, 36) = 1.183, p = 0.318 
S4  F (2, 36) = 2.117, p = 0.135 
S5  F (2, 36) = 0.998, p = 0.379 
R1  F (2, 36) = 2.770, p = 0.076 
R2  F (2, 36) = 3.887, p = 0.030 
R3  F (2, 36) = 1.393, p = 0.261 
R4  F (2, 36) = 2.831, p = 0.072 
R5  F (2, 36) = 1.515, p = 0.234 149 
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Appendix 2.19 
 
 
Investigation of Participant and Procedural Variables 
 
 
The table below indicates the number and percentage of participants in each group who took 
part in the experiment at different times of day.   
 
Time of Day of Participation 
 
  Good Sleeper  Insomnia  NREM 
  %  n  %  n  %  n 
Morning   33.3%  5  25.0%  3  27.3%  3 
Afternoon   40.0%  6  66.7%  8  36.4%  4 
Evening   26.7%  4  8.3%  1  36.4%  4 
 
 
Time of day was calculated according to the start time of the ECG recording as follows: 
Morning: start time = between 10am and 11.45am 
Afternoon: start time = between 11.46am and 4.45pm 
Evening: start time = between 4.46pm and 8.30pm 
 
Due to the categorical nature of the data and the small sample size, Fisher‟s exact test was 
used  to  investigate  the  relationship  between  time  of  day  and  group  allocation.    No 
relationship was found (p = 0.51). 
 
Participant perception of their performance (How well do you think you did?) and their 
actual performance (% correct responses) during the stressor phase was also investigated. 
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Participant Perception of Performance & Actual Performance During Stressor Phase 
  How well do you think 
you did? (0-10) 
% correct responses 
during stressor task 
  M  SD  M  SD 
GS  5.13  1.73  66.39%  14.47 
Insomnia  4.42  2.15  61.81%  23.56 
NREM  3.91  2.02  59.85%  18.38 
 
These data were examined for normality and homogeneity of variance.  The „Participant 
Perception‟ data were found to be normally distributed, and the groups were found to have 
equal variances. A one-way between groups ANOVA was therefore carried out.  Participant 
perception of how well they performed in answering the questions during the stressor phase 
did not significantly differ according to group membership [F (2, 35) = 1.29, p = 0.29]. 
 
The „% Correct‟ data were found to be normally distributed, however the variances were 
found  to  be  significantly  different  across  groups.    A  Kruskal-Wallis  test  was  therefore 
carried  out.    Participant  performance  in  terms  of  the  percentage  of  correctly  answered 
questions during the stressor phase did not differ significantly across groups [H(2) = 0.70, p 
= 0.71]. 
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Appendix 2.20 
 
Boxplot of Mean Heart Rate: GS Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Boxplot of Mean HR: Insomnia Group 
 
 
 
 
 
 
 
 
 
 
 
 
Boxplot of Mean HR: NREM Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: 
The boxplots show the range of 
scores with the box representing 
the interquartile range and the  line 
in the box representing the median. 154 
 
Note: 
The boxplots show the range of 
scores with the box representing 
the interquartile range and the 
line in the box representing the 
median. 
Boxplot of Mean CVT: GS Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Boxplot of Mean CVT: Insomnia Group 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Boxplot of Mean CVT: NREM Group 
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Appendix 2.21 
 
Three participants with extreme values whose CVT data does not follow the typical 
pattern of the group.  
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Description of the three participants with extreme values whose CVT data does not 
follow the typical pattern of the group 
 
  Participant GS13 
(Good Sleeper) 
Participant I6 (Insomnia)  Participant I19 
(Insomnia) 
Demographics  Female, 35  Female, 21  Male, 31 
Health  No physical or mental 
health problems reported, 
no medication. 
No physical or mental 
health problems reported, 
no medication. 
No physical or mental 
health problems reported, 
no medication. 
Alcohol  28 units per week  4 units per week  None 
Global PSQI  2  14  7 
DASS  Within normal range  Moderate depression (20) 
Moderate anxiety (10) 
Stress normal range 
Within normal range 
SCI  7  25  9 
Impact of Poor 
Sleep 
3  21  8 
Description of 
sleep disorder 
  Sleep-onset and -
maintenance insomnia; 
difficulties 7 nights per 
week; sleep problem for 4 
years; average 4 hours 
sleep/night. 
Sleep-onset and -
maintenance insomnia; 
difficulties 7 nights per 
week; sleep problem for 10 
years; average 6½ hours 
sleep/night. 
% correct 
responses 
during stressor 
task 
66.67%  50.00%  83.33% 
How well do 
you think you 
did? (0-10) 
6  3  6 
Subjective 
Stress (0-10): 
Initial stress 
Stress after B 
Stress after S 
Stress after R 
Overall stress 
 
 
5 
2 
8 
3 
6 
 
 
0 
0 
7 
3 
4 
 
 
3 
2 
4 
3 
4 
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Appendix 2.22 
 
 
Differences in Subjective Stress between Groups: Mann-Whitney U Test Results 
Stress Scale  NREM – GS  NREM – Insomnia  Insomnia - GS 
  U  z  p  U  z  p  U  z  p 
Initial Stress  66.50  -0.85  0.41  52.00  -0.57  0.59  78.00  -0.24  0.83 
After Baseline Phase  76.50  -0.33  0.76  61.00  -0.32  0.76  89.00  -0.05  0.98 
After Stressor Phase  51.50  -1.63  0.11  48.50  -1.10  0.29  78.00  -0.60  0.57 
After Recovery Phase  65.00  -0.95  0.35  41.00  -1.36  0.19  72.50  -0.54  0.61 
Overall Stress  80.50  -0.11  0.93  59.50  -0.41  0.70  84.50  -0.28  0.80 
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Effect size for Cohen‟s 
d: 
Small:   0.2 
Medium:   0.5 
Large:   0.8 
 
Appendix 2.23 
 
Summary of Effect Sizes (Cohen’s d) 
Baseline Autonomic Arousal 
Interaction  HR  CVT 
NREM - GS  0.34  -0.38 
NREM – Insomnia  0.03  -1.16 * 
Insomnia – GS  0.30  -0.63 
 
Stress Reactivity 
  HR  CVT 
Interaction  Change Score  AUC  Change Score  AUC 
NREM - GS  0.01  -0.04  -0.07  0.05 
NREM – Insomnia  0.38  0.66  -0.45  0.53 
Insomnia – GS  -0.40  -0.68  -0.37  0.50 
 
* significant result 
 
 
Achieved Power 
Baseline Autonomic Arousal 
Interaction  HR  CVT 
NREM - GS  0.13  0.15 
NREM – Insomnia  0.05  0.75 
Insomnia – GS  0.12  0.35 
 
Stress Reactivity 
  HR  CVT 
Interaction  Change Score  AUC  Change Score  AUC 
NREM - GS  0.05  0.05  0.05  0.05 
NREM – Insomnia  0.14  0.34  0.18  0.23 
Insomnia – GS  0.17  0.39  0.15  0.24 
 
Post hoc calculation of achieved power (independent t tests), given alpha (0.05), sample size 
and effect size (d). 
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Appendix 2.24: Research Proposal 
 
Introduction 
Parasomnias are “undesirable physical events or experiences that occur during entry into 
sleep, within sleep or during arousals from sleep”.  The International Classification of Sleep 
Disorders,  Second  Edition  (ICSD-2)  distinguishes  between  parasomnias  associated  with 
Non-REM (NREM) sleep, parasomnias associated with REM sleep, sleep-wake transition 
parasomnias as well as „other parasomnias‟ which are not classified by the other categories 
(American Academy of Sleep Medicine, 2005).  NREM parasomnias are the most common 
type of parasomnias (Wills & Garcia, 2002). 
There are three normal states that the nervous system can be in: wakefulness, NREM sleep 
and REM sleep.  Most parts of the nervous system are active across the three states, but in 
different  manners,  and  transitioning  between  states  is  a  complex  process  (Mahowald  & 
Bornemann, 2005). NREM parasomnias, also known as disorders of arousal, are incomplete 
arousals  from  slow-wave  NREM  sleep  which  result  in  behaviours  associated  with 
wakefulness.  Since arousal is incomplete, the brain is partially awake and partially remains 
in NREM sleep.   The three main NREM parasomnias are sleep terrors, sleepwalking and 
confusional arousals.  They generally occur during the first third of the night and during 
episodes behaviour can appear confused and semi-purposeful.  Individuals generally do not 
remember the events which tend to occur no more than once per night and can last from 
seconds  to  minutes  (Vaughn  &  O‟Neil,  2007).    Confusional  arousals  involve  mental 
confusion or confusional behaviour characterised by disorientation, slow speech, diminished 
mentation,  impaired  cognitive  response  and  inappropriate  behaviour.    Sleepwalking 
episodes often begin with the individual sitting up in bed and appearing confused before 
walking  or  engaging  in  more  complex  behaviours  such  as  dressing,  or  even  driving. 160 
 
Individuals may be emotionally calm or may be agitated. Violent behaviours are more likely 
to occur if attempts are made to wake the sleepwalker.  Sleep Terrors are characterised by 
intense  fear  which  is  evident  in  the  individual‟s  behaviour  and  autonomic  arousal.  
Individuals tend to suddenly sit up in bed, let out a piercing scream and can be inconsolable 
as well as unresponsiveness to external stimuli.  (American Academy of Sleep Medicine, 
2005). 
 
NREM  parasomnias  are  more  common  in  children  than  adults.    Whereas  NREM 
parasomnias  in  children  appear  to  often  be  associated  with  genetic  and  developmental 
factors,  persistence  (or  onset)  into  adolescence  or  adulthood  has  been  associated  with 
psychopathology (Kales, Kales et al., 1980; Kales, Soldatos, et al., 1980; Kales et al., 1982; 
Gau  &  Soong,  1999;  Ohayon  et  al.,  1999).    However,  many  individuals  with  NREM 
parasomnias  do  not  present  with  significant  psychopathology  and  in  fact  show  good 
psychosocial functioning (Mahowald, 2002; Mahowald & Borneman, 2005; Schenck et al., 
1997). 
 
NREM parasomnias are thought to occur as a result of a complex group of priming and 
precipitating factors in those that are genetically predisposed.  NREM parasomnias seem to 
be more likely to occur in the presence of factors that deepen sleep, fragment sleep or make 
arousal  from  sleep  more  difficult.  Factors  such  as  stress,  sleep  deprivation,  medication, 
alcohol and febrile illness can affect sleep and make the occurrence of NREM parasomnias 
more likely (Pressman, 2007; Mahowald & Borneman, 2005).  It is thought that a trigger is 
also necessary for a specific event to occur.  Triggers include noise, touch, and co-existing 
sleep disorders such as sleep disordered breathing or periodic leg movements in sleep. 
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Sleep disturbance and psychopathology commonly co-occur and there is a particularly high 
comorbidity between insomnia, anxiety and depression (Morin & Ware, 1996) with sleep 
difficulties being a symptom of both anxiety and depression.  The link between insomnia 
and stress is well documented.  Stress can have the effect of increasing arousal levels which 
can make it more difficult to fall, or stay, asleep (Morin et al., 2003).  Stress and anxiety 
have also been linked to NREM parasomnias (Mahowald & Borneman, 2005; Mahowald & 
Schenck, 2005; Pressman, 2007; Ohayon et al., 1999).  Insomnia and parasomnias are both 
psychophysiological conditions since they have both psychological and physical aspects.  
Anxiety  and  depression  are  also  examples  of  psychophysiological  conditions  although 
occurring  during  wakefulness  whereas  parasomnias  and  insomnia  occur  during  sleep  or 
incomplete arousal.   
 
Previous  research  has  found  that people  with  insomnia  show  greater  autonomic  arousal 
compared to normal sleepers (Bonnett & Arand, 1996, 1998; Adam et al., 1986; Stepanski 
et al., 1989, 1994; Haynes et al., 1981, 1974; Monroe, 1967; Freedman & Sattler, 1982; 
Riemann  et  al.,  2010),  suggesting  insomniacs  react  more  readily  to  stressors  at  a 
physiological level.  Autonomic arousal occurs as the 'fight or flight' response and has often 
been used as a measure of stress reactivity (Boyce et al. 2001) since it is an indication of 
how an individual responds at a physiological level to stressful or threatening events.  Since 
autonomic arousal is closely related to emotion it makes sense that individual differences in 
autonomic arousal in response to stress may be linked to the development of symptoms of 
psychopathology.  Studies have found individual differences in autonomic arousal to be 
been associated with psychopathology in both adults (e.g. Raine, 1996; Rechlin et al., 1994; 
Felsten, 2002; 2004) and children (e.g. Boyce et al., 2001).  Felsten, for example, reported 162 
 
associations  between  stress  reactivity,  neuroticism  and  a  vulnerability  to  stress  and 
depressed mood.   
There  appears  to  be  a  gap  in  the  literature  with  regards  experimental  studies  of  stress 
reactivity  amongst  people  with  NREM  parasomnias  and  it  would  be  interesting  to 
investigate this area in order to gain further insight into daytime functioning of this group.  
In addition to looking at how individuals react to stressors physiologically, baseline levels 
of autonomic arousal in the absence of a stressor would provide insight into daytime arousal 
levels as a trait-like feature.  To date, there is little research into either stress reactivity or the 
specificity of psychological characteristics in particular forms of sleep disorder.  This study 
is designed to make comparisons between two types of sleep disorder: NREM parasomnias 
and insomnia. 
 
Aims and Hypotheses 
The aim of this study is to investigate stress reactivity in people with NREM parasomnias 
by measuring autonomic arousal across three conditions: (1) at baseline, (2) in reaction to a 
psychological  stressor  and  (3)  time  taken  to  return  to  baseline.    People  with  NREM 
parasomnias will be compared to two control groups: a primary insomnia control group (PI) 
and a good sleeper control group (GS).  Using a clinical control group in addition to the 
good  sleeper  control  group  will  allow  comparison  of  the  NREM  group  to  a  group  of 
individuals  with  another  sleep  disorder.    This  will  allow  better  discrimination  between 
findings  associated  with  NREM  parasomnias  specifically,  and  those  associated  with 
disordered sleep more generally.  An insomnia group was chosen as the clinical control 
since, like NREM parasomnias, insomnia is also psychophysiological in nature. 
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It  is  hypothesised  that  the  PI  group  will  show  increased  autonomic  arousal  at  resting 
baseline, greater stress reactivity and a slower return to baseline in comparison to good 
sleepers.  
 
It is thought that the NREM group will also show increased autonomic arousal at baseline, 
greater stress reactivity and a slower return to baseline in comparison to good sleepers since 
NREM  parasomnias  are,  inherently,  (triggered)  arousal  disorders  as  well  as  also  being 
psychophysiological in nature.  This prediction for the NREM group, however, is based on 
rationale rather than evidence and so ultimately remains a research question. The nature of 
the difference in autonomic arousal between the NREM and PI groups remains a research 
question.  A subjective, self-report measure of stress will also be employed and the nature of 
how this will differ between groups remains a further research question. The PI group is 
predicted to report higher levels of stress than good sleepers. Morin et al. (2003) found that 
insomniacs tend to appraise their lives as more stressful than good sleepers even though 
both groups reported similar levels of stressors. It will be interesting to investigate how the 
NREM group‟s subjective measures of stress compare to the two control groups.  Clinical 
observations of clients presenting with  NREM parasomnias at the Glasgow Sleep Centre 
suggest a tendency to appear to cope well with challenges and stress, although perhaps 
superficially.  Clinicians report individuals to appear carefree and unperturbed with regards 
stressors although an underlying emotional vulnerability may be evident.  It is therefore 
predicted that individuals in the NREM group may report lower levels of stress than the PI 
group.  Such individuals may be described as repressors.  Weinberger et al. (1979) identified 
repressors  as  individuals  with  low  trait  anxiety  but  high  defensiveness.    They  found 
repressors to respond to stressful situations with high physiological arousal suggestive of 
anxiety.  However,  they  also  showed  a  tendency  to  avoid  disturbing  cognitions,  deny 164 
 
cognitive anxiety and report low trait anxiety.  Derakshan & Eysenck (1999) concluded 
from their study that repressors truly believe themselves to be low in trait anxiety and that 
there  may  be  avoidance  or  cognitive  biases  working  at  a  subconscious  level  to  inhibit 
awareness of anxiety. 
 
In summary, it is hypothesised that both the NREM and the PI group will show indications 
of stress reactivity on objective physiological measures.  It is also hypothesised that the PI, 
but not the NREM group, will report high levels of stress subjectively. 
 
A parallel questionnaire-based self-report survey  study is also being planned (Katherine 
Hooker).  This parallel study will aim to investigate state and trait arousal (pre-sleep arousal 
and arousal pre-disposition respectively), worry, rumination and emotional inhibition across 
NREM parasomnia, insomnia and good sleeper groups. Measures of sleep quality, anxiety, 
depression  and  stress  will  also  be  included  as  part  of  the  screen.      It  is  hoped  that 
participants in this study will also take part in the parallel survey study by telephone, post or 
online, prior to their involvement in this study, although it will not be compulsory.  This 
would then allow for descriptions of the three groups in this study, in terms of the above 
elements, to be produced and compared.  If there are any participants who choose not to 
take part in the parallel study, missing questionnaire data will be sought.  
 
Method 
Design 
The study will employ a mixed design.  Participants will belong to independent groups 
(NREM, PI or GS) and each group will participate in baseline, stress and return to baseline 
conditions.  The NREM group will be compared to two control groups: the clinical control 165 
 
(PI) group and good sleepers. The independent variable is the presence or absence of a non-
REM  parasomnia,  insomnia  or  good  sleep according  to  defined  criteria. The  dependent 
variables are: (1) autonomic arousal at resting baseline, (2) stress reactivity i.e. autonomic 
arousal in response to stress in comparison to baseline, (3) time taken for autonomic arousal 
to return to baseline, (4) a subjective, self-report measure of stress. 
 
Participants 
Participants will meet ICSD-2 criteria for either a NREM parasomnia or insomnia, or meet 
research  diagnostic  criteria  for  good  sleep.  The  prevalence  rates  in  the  general  adult 
population  for  confusional  arousals  and  for  sleepwalking  are  thought  to  each  be 
approximately 4%.  Sleep terrors are thought to occur in up to 3% of the general adult 
population (Ohayon et al., 1999). Participants in the three groups will be matched for age, 
gender and socio-economic status (determined by post code).  Participants will be recruited 
from the general population through the media, advertisements and clinical referrals in a 
manner consistent with the University of Glasgow Sleep Centre‟s (UGSC) experience and 
operational procedures.   In the past, recruitment in this way at the UGSC has yielded good 
response rates and spontaneous referrals are also common.  Advertisements may be placed, 
for example, in publications e.g. newspapers or the UGSC newsletter, in public spaces e.g. 
in  hospitals,  and  on  the  internet  e.g.  on  the  UGSC  website.    Participants  may  also  be 
identified via an existing database held at the UGSC which has details of participants who 
have not been suitable for previous research and have agreed to be contacted for future 
studies. Additionally, some potential participants may be identified through the parasomnia 
clinic which is ongoing at the UGSC. All clinic attendees receive a general letter saying that 
we have research projects in which they may be interested. If they express an interest they 
will be given the participant information sheet and follow up phone calls will be made in the 166 
 
same manner as with other potential participants. This study is planned to be part of a larger 
programme of research and recruitment may come directly as well as via a parallel study 
(Katherine Hooker).  Suitable participants recruited into the parallel study will be offered 
the opportunity to take part in this study and vice versa.   
 
It is expected that people interested in participating in the study will contact the UGSC to 
declare this  interest.   Potential  participants  would  be  screened  via telephone  which  will 
include the following: 
  Standard  screening  interview  which  is  administered  to  all  potential  research 
participants at the UGSC with additional questions relating  to health and socio-
demographic  factors  as  well  as  International  Classification  of  Sleep  Disorders 
(ICSD-2) diagnostic criteria for insomnia and Non-REM parasomnias. 
  Pittsburgh Sleep Quality Index (PSQI)  
  Depression Anxiety Stress Scales (DASS)  
  Sleep Condition Indicator (SCI)  
Further details of the screening measures are included in the proposal for the parallel study 
(Katherine Hooker).  If deemed suitable according to the inclusion/exclusion criteria defined, 
potential  participants  will  be  sent  information  sheets  regarding  both  studies  as  well  as 
consent forms.  As part of the information provided, they will be informed that participants 
will be asked to abstain from caffeine, exercise, alcohol and cigarettes for a period of 4 
hours prior to the visit.  The potential participants will also be informed that this study may 
highlight cardiac problems or psychopathology and will be informed of the action that will 
be taken if such a situation should arise. Potential participants will subsequently be given 
time  to  consider  if  they  wish  to  participate  before  a  follow-up  phone  call  is  made 167 
 
approximately one week later.  Those who agree at this stage to participate in this particular 
study  will  either  immediately  be  given  further  instructions  for  attending  the  UGSC  to 
participate, or will be informed that they will be contacted at a later date with further details. 
 
Inclusion Criteria:  
Participants will meet The International Classification of Sleep Disorders, Second Edition 
(ICSD-2) criteria for either a NREM parasomnia or insomnia, or meet research diagnostic 
criteria for good sleep.  Participants will be aged 18 years and over. 
 
Exclusion Criteria:  
Individuals will be excluded if they do not meet criteria for a NREM parasomnia, insomnia 
or good sleep or if they meet criteria for both a NREM parasomnia and insomnia since 
participants must only belong to one group. Other exclusion criteria include:  other sleep 
disorders  e.g.  sleep  apnoea  or  restless  leg  syndrome  (RLS),  neurological  disorders  e.g. 
narcolepsy or epilepsy, cardiac problems, pregnancy and medications affecting HR.  NREM 
parasomnias are sometimes seen as symptoms of sleep disordered breathing and RSL, and 
treatment of these disorders has been shown to eliminate the parasomnia. Guilleminault et al. 
(1996)  reports  that  28.2%  of  children  aged  8-12  with  sleep  disordered  breathing  report 
sleepwalking.  Klackenberg (1987) reports a prevalence rate of 15% for sleepwalking in 
children  aged  5-12.    Provini  et  al.  (1999)  reported  that  34%  of  100  individuals  with 
nocturnal frontal lobe epilepsy reported a personal history of parasomnias. 
 
Individuals with DSM based Axis 1 psychiatric disorders will be excluded if their symptoms 
are severe and/or untreated.  Individuals with stable and treated symptoms may be included.  
Their symptoms will be observed and noted and will be taken account of in the analysis as a 168 
 
co-variate  if  appropriate.  Ohayon  et  al.  (1999)  reported  higher  rates  of  mood  disorders 
(30.4%  of  those  with  night  terrors  and  14.6%  of  sleep  walkers)  and  anxiety  disorders 
(34.2% of those with night terrors and 12.7% of sleep walkers) compared to controls (5.7% 
and 4.7% respectively).   
 
Measures  
Autonomic arousal will be measured via ECG recordings of HR and CVT.   UGSC standard 
operational  policy  will  be  followed  for  electrode  attachment  and  recording.    HR  is 
continually  under  the  influence  of  both  sympathetic  and  parasympathetic  activity,  each 
having an antagonistic but complementary influence (Sherwood, L., 2010).  Sympathetic 
activity has the effect of quickening HR while parasympathetic (vagal) tone slows it down.  
Vagal tone affects HR more quickly (within one heart beat) than sympathetic activity, thus it 
is vagal tone which is responsible for rapid changes in HR (Little et al., 1999).  HR and 
CVT will be recorded throughout all phases producing continuous data.  Average values 
will  be  taken  from  specific,  stable  periods  of  each  phase,  allowing  for  a  period  of 
stabilisation at the beginning of each phase.  Prior to the study commencing, training will be 
provided by the UGSC on autonomic measurement and analysis. 
 
A  subjective,  self-report  measure  of  stress  will  also  be  employed  at  various  times 
throughout the process.  Participants will be asked to rate their level of stress using a visual-
analogue scale ranging from 0 - 10.  The exact nature of this scale and the times the points 
at which it will be used will be determined during a pilot of this study. 
 
 
 169 
 
Research Procedures  
On  arrival  at  the  UGSC  information  about  the  study,  the  right  to  withdraw  and 
confidentiality will be discussed.  Participants will be informed that the study may highlight 
cardiac problems or psychopathology and consent will be obtained.  An interview will be 
conducted  in  which  the  Mini  International  Neuropsychiatric  Interview  (MINI),  a 
standardised measure, will be used to screen for DSM-based Axis 1 disorders. 
 
The study will be carried out at the UGSC at the Southern General Hospital.  The room used 
will  be  quiet  and  the  light  level  and  temperature  will  be  standardised  to  ensure  calm, 
pleasant  surroundings.    Time  of  day  may  make  a  difference  to  measures  of  autonomic 
arousal.  Participants will be asked to attend within the time period of e.g. between 10-4pm 
and a scheme will be put in place to overcome time of day as a confounding factor between 
groups.  It is expected that participants will lie in a prone position (without using postural 
muscles) on the bed with their head resting on pillows so that a computer screen, which will 
be positioned a set distance from the participant, can be comfortably viewed.  It is thought 
that one hand will rest on a pillow with a button press and participants will be told to remain 
as still as possible throughout, other than pushing the response button, since movement will 
affect the measures.  A script  will be used to provide instructions and participants will 
progress through five phases.  The exact nature and length of phases will be determined by 
the pilot study but it is likely that each will continue for five minutes before the subsequent 
phase commences, taking a total of twenty five minutes.  The initial resting baseline phase 
(RB) will involve participants relaxing whilst looking at a relaxing image on the computer 
screen.  The initial stress phase (S1) will involve participants carrying out a difficult task e.g. 
a mathematical serial subtraction task using complex numbers. The exact nature of the task 
will be established out of the pilot study.  Stimulus presentation software (SuperLab) will be 170 
 
used to programme the computer to present the stimuli and participants will respond using 
the button press with two fingers to provide yes/no or true/false responses.  Following phase 
S1, baseline conditions will be repeated (phase R2) followed by a second stress phase (S2) 
with unseen stimuli before phase R3 in which baseline conditions will be again repeated. 
Thus, the five phases will run in the following order: RB, S1, R2, S2, R3.  HR and CVT will 
be measured continuously throughout all phases.  Phase R3 can be extended if necessary to 
allow arousal to return to baseline levels before participants are debriefed and thanked. 
 
Lab Protocol Development and Testing 
As  part  of  the  developmental  stage,  a  pilot  study  will  be  carried  out  with  the  help  of 
volunteers in order to inform and validate the experimental procedure.  The pilot study will 
be used to establish whether the stimuli will in fact induce the desired stress response.   It 
may be appropriate to prime such a response by manipulating the experimental instructions 
at the outset or by altering the stimuli (e.g. frequency of presentation or complexity of the 
numbers) and this will be considered during the pilot. Some individuals are likely to find the 
procedure more stressful than others in all three groups and this variation is expected to be 
normally distributed.  Differences in how stressful individuals find the experimental task 
will be considered during the pilot study and it is hoped that by measuring stress reactivity 
relative to each individuals' baseline, this difference will not become a confounding variable. 
The  pilot  will  be  conducted  in  two  stages.    An  initial  pilot  will  be  carried  out  with 
volunteers without the use of electrodes to record autonomic arousal.  Subjective measures 
of stress will be employed in order to find out how stressful the task is found to be.  The task 
level should be considered difficult and the success rate should not be too high.  Autonomic 
arousal will be measured during the second stage of the pilot with the aim of investigating 
the  pattern  of  autonomic  arousal  across  phases  and  how  long  it  takes  for  participants‟ 171 
 
arousal to return to baseline.  It will be important to determine, for example, whether acute 
stress is experienced before habituation as this will inform which portions of continuous 
data will be used to provide average values for further analysis.  The second stage of the 
pilot will also be used to establish the total time needed to sufficiently test each participant. 
The aim will be to keep the time as short as possible with no more than two hours (and quite 
possibly less) estimated for each participant. Following the pilot, the study will be carried 
out on experimental participants. 
 
Justification of sample size 
A  prior  study  in  which  HR  and  CVT  have  been  measured  in  two  clinical 
psychophysiological  sleep  disorder  populations  has  not  been  identified.  A  recent  study 
(Espie et al., unpublished abstract) found statistically significant differences in HR and CVT 
in individuals with insomnia (n=8) compared to normal sleepers (n=9).  A medium-large (d 
= 0.75) effect size was found for HR and a large effect size was found (d = 1.63) for CVT.    
This study involved the comparison of one a clinical group with a control.  Since this is a 
preliminary study, both the effect size and sample size must be estimated. The primary 
research question of whether stress reactivity in reaction to a psychological stressor in a 
sleep disordered group will significantly differ from stress reactivity in clinical or good 
sleeper control groups has never before been addressed.  This study can therefore hope to 
provide a definitive answer of how to power future studies.   The power calculation is based 
on the hypothesis that a significant difference in stress reactivity will be found between 
groups.  Stress reactivity will be a measure of the difference between autonomic arousal in 
response to stress and baseline autonomic arousal. A replication design will be utilised to 
strengthen the study, involving two stress phases, each followed by a return to baseline 
conditions.  A total sample size of 66 participants (22 per group) was calculated for a one-172 
 
way ANOVA using an effect size of 0.4 (f²), a significance level of 0.05 and standard power 
of 0.8. It is therefore proposed that 22 participants should be recruited to each of the three 
groups.   If a larger effect size (0.45 or 0.5) was to be used in the calculation, then it would 
be proposed that a total sample size of 51 or 42 respectively (17 or 14 per group) should be 
recruited. 
   
Settings & Equipment 
  A bedroom at the UGSC, Southern General Hospital. 
  Cover sheet for the bed. 
  ECG will be recorded using a Lifelines Trackit recorder and disposable wet gel ECG 
electrodes.  Energiser (Ultimate/Ultra) 9V batteries will also be required. 
  SuperLab stimulus presentation software. 
  A laptop and an appropriate stand to position the screen correctly. 
 
Data Analysis  
A continuous ECG output will be recorded and analysed using the NeuroScope
TM method 
(Little et al., 1999), yielding HR (beats per minute; bpm) and the non-invasive index of 
CVT (linear vagal scale; LVS) on a continuous beat-to-beat bases.  Average values will be 
calculated for particular periods in each phase in which data has stabilised.  Data will be 
exported to Excel and SPSS for analysis.  Normative data will be obtained from the UGSC.  
The demographic data will be analysed to look for similarities between groups with regards 
gender, age and SES.  Any differences between groups will be introduced as a covariate in 
the analysis.  ANOVAs will be used to compare groups for each dependent variable.  Dr 173 
 
Stig  Hansen  and  Christine  Salveta  will  also  advise  on  data  analysis  (from  a  technical 
standpoint). 
 
Health and Safety Issues 
Researcher Safety Issues 
The study will only be carried out at pre-arranged times at the UGSC when other staff 
members are present.  Sleep Centre staff will be kept informed regarding the participant 
schedule. 
 
Participant Safety Issues 
If necessary, participants will be given extra time to relax at the end of their participation to 
ensure autonomic arousal has returned to baseline level.  Researchers will be trained by the 
UGSC  in  autonomic  measurement  prior  to  the  study  commencing  and  UGSC  standard 
operational policy for electrode attachment, removal and recording will be adhered to. 
 
Ethical Issues   
This study employs the use of a mild psychological stressor.  Participants will engage in a 
period of relaxation following the stressor which will allow their level of arousal to subside 
and return to baseline.  Participants will not be left in a stressed state at the end of the study.  
They will be asked to rate their level of stress at the end of the study and if they indicate 
feeling  stressed,  further  opportunity  for  relaxation  will  be  given.    There  is  standard 
operational policy regarding procedures for attaching and removing electrodes in place at 
UGCC which will be adhered to. Participants will be warned prior to giving consent both 
verbally and via an information sheet, that the study may highlight cardiac problems or 
psychopathology.  If evidence of a condition is found, or any indication of an unusual ECG 174 
 
recording, this will be discussed and participants will be provided with advice, information 
and referrals as necessary. Details of participants‟ GPs will be recorded at the outset and 
informed consent will be sought regarding contacting the GP on the participant's behalf 
should a serious cardiac or psychiatric disorder be suspected.  
 
Arrangements to give feedback regarding the study will be made if requested. Adequate 
time  and  information  will  be  provided  to  allow  participants  to  make  informed  consent 
regarding their involvement. Confidentiality and data protection protocol will be observed.  
Data  will  be  anonymised  data  and  securely  stored.  Participant  time  will  be  kept  to  a 
minimum.  
 
Financial Issues 
Photocopying, letters & postage, bed cover, ECG electrodes (3 per person) and 9V batteries 
(1 per day). 
 
Timetable 
The study will be carried out between October 2010 and May 2011. 
 
Practical Applications 
The  outcome  of  this  study  could  help  inform  interventions  for  individuals  with  NREM 
parasomnia.   
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